inositol has been researched along with Pregnancy in 303 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study strove to investigate the hypothesis that a low dosage of myo-inositol supplementation might decrease the likelihood of gestational diabetes in overweight, pregnant women." | 9.69 | The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. ( Basirat, Z; Delavar, MA; Esmaeilzadeh, S; Ghadimi, R; Mashayekh-Amiri, S, 2023) |
| "To determine whether a combined myo-inositol, probiotics and micronutrient nutritional supplement impacts time-to-natural-conception and clinical pregnancy rates." | 9.69 | Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics, and micronutrient supplement: secondary outcomes of the NiPPeR randomized trial. ( Baker, PN; Barton, SJ; Chan, SY; Chang, HF; Chong, YS; Cutfield, WS; Ebreo, M; El-Heis, S; Godfrey, KM; Kenealy, T; Loy, SL; Nield, H; Ong, J; Tan, KM; Titcombe, P; Wong, JT, 2023) |
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 9.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women." | 9.41 | Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. ( Caruso, S; Cianci, A; Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Vitale, SG, 2021) |
| "To verify whether myo-inositol plus α-lactalbumin may reduce insulin resistance and excessive fetal growth in women with gestational diabetes mellitus." | 9.41 | Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. ( Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Gullo, G; Loddo, S, 2021) |
| "This trial will provide evidence for the effectiveness of myo-inositol supplementation during pregnancy in reducing the incidence of gestational diabetes mellitus." | 9.34 | Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. ( Anastasiou, E; Antsaklis, P; Asimakopoulos, G; Daskalakis, G; Kallergi, A; Loutradis, D; Pergialiotis, V; Sindos, M; Theodora, M; Vogiatzi, E, 2020) |
| "The purpose is a comparison of effectiveness of myo-inositol and metformin in infertile women with polycystic ovary syndrome (PCOS) treated with letrozole." | 9.30 | The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. ( Bazarganipour, F; Kutenaee, MA; Pourghasem, S; Taghavi, SA, 2019) |
| "Objectıve: The aim of the study is to investigate the effect of myo-inositol (MYO) on pregnancy rates of patients diagnosed with polycystic ovary syndrome (PCOS) who undergone controlled ovulation induction and intrauterine insemination (IUI)." | 9.24 | Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. ( Çağlıyan, E; Emekçi Özay, Ö; Gülekli, B; Okyay, RE; Özay, AC, 2017) |
| "To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women." | 9.22 | Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A, 2016) |
| "Although peri-conceptional folic acid (FA) supplementation can prevent a proportion of neural tube defects (NTD), there is increasing evidence that many NTD are FA non-responsive." | 9.22 | Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. ( Burren, K; Chitty, LS; Copp, AJ; Gay, V; Greene, ND; Leung, KY; Mills, K, 2016) |
| "The aim of the present study is to evaluate the effectiveness of myo-inositol alone or in combination with clomiphene citrate for (1) induction of ovulation and (2) pregnancy rate in anovulatory women with PCOS and proven insulin resistance." | 9.20 | Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. ( Carlomagno, G; Gateva, A; Genazzani, AD; Kamenov, Z; Kolarov, G, 2015) |
| "The supplemental administration of myo-inositol, D-chiro-inositol, folic acid and manganese (MDFM) was tested in a prospective, randomized, double-blind, placebo controlled clinical trial, pilot study, to test the hypothesis that its supplemental administration in the second trimester of pregnancy would improve glucose and glycemic parameters and blood pressure." | 9.19 | Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. ( Casciaro, F; Creanza, A; Di Renzo, GC; Kosmas, I; Malvasi, A; Minervini, MM; Monti Condesnitt, V; Mynbaev, OA; Pacella, E; Tinelli, A, 2014) |
| "To test the hypothesis that dietary myo-inositol may improve insulin resistance and the development of gestational diabetes mellitus (GDM) in women at high risk of this disorder." | 9.17 | Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. ( Celentano, C; D'Angelo, M; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2013) |
| "To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes." | 9.15 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giordano, D; Pintaudi, B; Santamaria, A, 2011) |
| "melatonin ameliorates the activity of myo-inositol and folic acid by improving oocyte quality and pregnancy outcome in women with low oocyte quality history." | 9.14 | Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. ( Benedetto, V; Raffone, E; Rizzo, P, 2010) |
| "The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM)." | 8.98 | The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. ( Gateva, A; Kamenov, Z; Unfer, V, 2018) |
| " Insulin-sensitising agents such as metformin may be effective in treating PCOS-related anovulation." | 8.95 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Morley, LC; Norman, RJ; Tang, T; Yasmin, E, 2017) |
| " Myoinositol supplement was associated with significantly improved clinical pregnancy rate [95% confidence interval (CI), 1." | 8.95 | Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. ( Li, S; Lin, D; Lin, Y; Song, J; Sun, Y; Zhang, Y; Zheng, X, 2017) |
| " Maternal periconceptional supplementation with folic acid significantly reduces the risk of an NTD-affected pregnancy, but does not prevent all NTDs, and "folic acid non-responsive" NTDs continue to occur." | 8.95 | Inositol, neural tube closure and the prevention of neural tube defects. ( Copp, AJ; Greene, ND; Leung, KY, 2017) |
| "Although inositol dietary deficiency in the general population has not been demonstrated at the serum level, several findings are emerging regarding the impact of inositol supplementation in periconceptional period and in early phases of pregnancy." | 8.93 | Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications. ( Abdulrahim, B; Borgato, S; Gizzo, S; Noventa, M; Quaranta, M; Vitagliano, A, 2016) |
| "Evidence from four trials of antenatal dietary supplementation with myo-inositol during pregnancy shows a potential benefit for reducing the incidence of gestational diabetes." | 8.91 | Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. ( Alsweiler, J; Brown, J; Crawford, TJ; Crowther, CA, 2015) |
| "In agreement with the previous review, metformin was associated with improved clinical pregnancy but there was no evidence that metformin improves live birth rates whether it is used alone or in combination with clomiphene, or when compared with clomiphene." | 8.88 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Lord, JM; Norman, RJ; Tang, T; Yasmin, E, 2012) |
| "In agreement with the previous review, metformin is still of benefit in improving clinical pregnancy and ovulation rates." | 8.86 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Lord, JM; Norman, RJ; Tang, T; Yasmin, E, 2010) |
| "Supplementation with myo-inositol during the periconceptional period of pregnancy may ameliorate the recurrence risk of having a fetus affected by a neural tube defect (NTD; e." | 8.02 | Maternal Inositol Status and Neural Tube Defects: A Role for the Human Yolk Sac in Embryonic Inositol Delivery? ( Copp, AJ; D'Souza, SW; Glazier, JD; Greene, NDE, 2021) |
| "Inositols (INOs) supplementation during pregnancy, specifically the combination of myo-inositol (MI) and D-chiro-inositol (DCI), has been reported to improve vascular parameters in women with gestational diabetes mellitus." | 7.91 | Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. ( Alrais, M; Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Refuerzo, JS; Sibai, BM; Tamayo, EH, 2019) |
| "Authors would like to demonstrate the beneficial effect of myo-inositol supplementation in a pregnant woman with insulin-dependent type 2 diabetes mellitus and polycystic ovary syndrome." | 7.85 | [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome]. ( Kun, A; Tornóczky, J, 2017) |
| "Our study aims to demonstrate that the use in the preconceptional period until the 24th week of pregnancy of inositol and folic acid, first of all, preserves the product of conception from neural tube defects (NTDs) and then, thanks to inositol supplementation, it possibly counteracts and prevents the onset of maternal gestational diabetes (GDM)." | 7.85 | Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. ( Allegretti, A; Benedetto, M; Capalbo, A; D'Apice, MR; Dell'Edera, D; Epifania, AA; Lupo, MG; Sarlo, F; Simone, F, 2017) |
| "Myoinositol and D-chiroinositol improve insulin resistance in women with obesity and gestational diabetes and in postmenopausal women with metabolic syndrome." | 7.83 | The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. ( Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Ontiveros, AE; Refuerzo, JS; Roberts, RP; Saade, MM; Sibai, BM, 2016) |
| "In recent years, interest has been focused to the study of the two major inositol stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as second messengers of insulin, in several insulin-dependent processes, such as metabolic syndrome and polycystic ovary syndrome." | 7.81 | Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. ( Benvenga, S; Bevilacqua, A; Bizzarri, M; Carlomagno, G; Cavalli, P; Chiu, TT; D'Anna, R; Devroey, P; Di Renzo, GC; Facchinetti, F; Gerli, S; Hod, M; Kamenov, ZA; Lanzone, A; Oliva, MM; Soulage, C, 2015) |
| "In an attempt to evaluate the role of inositol supplementation in insulin-resistant patients with polycystic ovary syndrome (PCOS), undergoing gonadotropin ovulation induction using the low-dose step-down regimen, we conducted a prospective longitudinal study comparing the stimulation characteristics of 15 patients treated with inositol, to a cohort, matched by age and body mass index (BMI), without inositol." | 7.77 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. ( De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Orvieto, R, 2011) |
| "Neural tube defects (NTDs), most commonly spina bifida and anencephaly, can be prevented with periconceptional intake of folic acid in about 70% of cases." | 7.77 | Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. ( Cavalli, P; Grosso, E; Poggiani, C; Tonni, G, 2011) |
| "To determine the blood concentrations of myo-inositol, glucose and zinc before, during and after normal pregnancy." | 7.73 | Myo-inositol, glucose and zinc concentrations determined in the preconceptional period, during and after pregnancy. ( Groenen, PM; Merkus, HM; Peer, PG; Roes, EM; Steegers, EA; Steegers-Theunissen, RP, 2006) |
| "To investigate myo-inositol, glucose and zinc status in mothers and their infants on cleft lip with or without cleft palate risk (CLP)." | 7.72 | Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study. ( Brussel, W; Krapels, IP; Rooij, IA; Spauwen, PH; Steegers-Theunissen, RP; Wevers, RA; Zielhuis, GA, 2004) |
| "Among mouse genetic mutants that develop neural tube defects (NTDs), some respond to folic acid administration during early pregnancy, whereas NTDs in other mutants are not prevented." | 7.71 | D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. ( Allan, G; Cogram, P; Copp, AJ; Greene, ND; Tesh, J; Tesh, S; Wade, A, 2002) |
| " The present experiment was designed to determine: 1) if hyperglycemia-induced membrane injury is associated with intracellular and/or extracellular lipid disturbances; 2) if supplemental myo-inositol therapy prevents hyperglycemia-induced embryopathy; 3) if a correlation exists between dietary myo-inositol, serum and tissue levels of myo-inositol, and conceptus development; and 4) the cellular content of arachidonic acid following myo-inositol supplementation." | 7.70 | Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. ( Borenstein, M; Khandelwal, M; Reece, EA; Wu, YK, 1998) |
| "Lens fiber swelling and related cataractous outgrowth positively correlated to the degree of lens bSMIT gene expression and intralenticular myo-inositol content." | 7.70 | A transgenic animal model of osmotic cataract. Part 1: over-expression of bovine Na+/myo-inositol cotransporter in lens fibers. ( Cammarata, PR; Chen, G; Kuszak, JR; Reeves, RE; Robinson, ML; Singh, I; Zhou, C, 1999) |
| " It has been reported that a substantial proportion of NTD in humans can be prevented by folic acid (FA) supplementation prior to conception and during the first months of pregnancy, and myo-inositol (MI) was shown to reduce the incidence of NTD in curly tail mice which are not prevented by FA." | 7.70 | Folic acid supplementation of pregnant mice suppresses heat-induced neural tube defects in the offspring. ( Shin, JH; Shiota, K, 1999) |
| "Clinical trials demonstrate that up to 70% of neural tube defects (NTDs) can be prevented by folic acid supplementation in early pregnancy, whereas the remaining NTDs are resistant to folate." | 7.69 | Inositol prevents folate-resistant neural tube defects in the mouse. ( Copp, AJ; Greene, ND, 1997) |
| " The current investigation was undertaken to assess the use of dietary myo-inositol supplementation as a pharmacologic prophylaxis to obviate the teratogenic effects of hyperglycemia in an in vivo study." | 7.69 | Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. ( Borenstein, M; Khandelwal, M; Reece, EA; Wu, YK, 1997) |
| "Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of inositol trisphosphate (the putative second-messenger for oxytocin-stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy." | 7.68 | Oxytocin-stimulated inositol phosphate turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins. ( Bazer, FW; Davis, M; Mirando, MA; Ott, TL; Vallet, JL, 1990) |
| "We have shown that myo-inositol in the cultured rat embryo is diminished whenever malformations are induced by hyperglycemia and that the malformations and reductions of tissue myo-inositol content are not corrected by aldose reductase inhibitors." | 7.68 | Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. ( Freinkel, N; Garcia-Palmer, FJ; Weigensberg, MJ, 1990) |
| "Pregnancy is similarly characterized by substantial and complex changes in glycemic and lipidomic regulation as part of maternal adaptation and is also associated with physiological alterations in inositol processing." | 6.82 | A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. ( Chan, SY; Sharma, N; Watkins, OC; Yong, HEJ, 2022) |
| "Myo-inositol is a simple and safe treatment that is capable of restoring spontaneous ovarian activity and consequently fertility in most patients with PCOS." | 6.73 | Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. ( Baillargeon, JP; Brigante, C; Cino, I; De Santis, L; Ferrari, A; Fusi, F; Marelli, G; Papaleo, E; Redaelli, A; Unfer, V, 2007) |
| "Pregnancy is characterized by a physiologic increase in insulin resistance, which, associated with increased oxidative stress and inflammations, could induce alterations of glucose metabolism and diabetes." | 6.61 | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. ( Baldassarre, MPA; Bucci, I; Carlucci, MA; Consoli, A; Formoso, G; Ginestra, F, 2019) |
| "This study strove to investigate the hypothesis that a low dosage of myo-inositol supplementation might decrease the likelihood of gestational diabetes in overweight, pregnant women." | 5.69 | The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. ( Basirat, Z; Delavar, MA; Esmaeilzadeh, S; Ghadimi, R; Mashayekh-Amiri, S, 2023) |
| "To determine whether a combined myo-inositol, probiotics and micronutrient nutritional supplement impacts time-to-natural-conception and clinical pregnancy rates." | 5.69 | Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics, and micronutrient supplement: secondary outcomes of the NiPPeR randomized trial. ( Baker, PN; Barton, SJ; Chan, SY; Chang, HF; Chong, YS; Cutfield, WS; Ebreo, M; El-Heis, S; Godfrey, KM; Kenealy, T; Loy, SL; Nield, H; Ong, J; Tan, KM; Titcombe, P; Wong, JT, 2023) |
| "The research confirmed that myo-inositol supplementation can improve global sleep quality, subjective sleep quality, and sleep duration during pregnancy." | 5.51 | The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study. ( Bakouei, F; Delavar, MA; Esmaeilzadeh, S; Faramarzi, M; Mashayekh-Amiri, S, 2022) |
| "The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling." | 5.43 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. ( Koos, B; Markovic, D; Murphy, A; Ostlund, R; Shamshirsaz, A, 2016) |
| "Evidence from seven studies shows that antenatal dietary supplementation with myo-inositol during pregnancy may reduce the incidence of gestational diabetes, hypertensive disorders of pregnancy and preterm birth." | 5.41 | Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes. ( Alsweiler, J; Crawford, TJ; Crowther, CA; Lin, L; Motuhifonua, SK, 2023) |
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 5.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "To evaluate the benefits of myoinositol plus metformin versus myoinositol alone in infertile polycystic ovarian syndrome (PCOS) women undergoing ovulation induction cycles." | 5.41 | Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial. ( Bhatla, N; Gupta, M; Kachhawa, G; Khadgawat, R; Kumari, R; Mahey, R; Prabhakar, P; Sharma, JB; Vanamail, P, 2021) |
| "This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women." | 5.41 | Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. ( Caruso, S; Cianci, A; Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Vitale, SG, 2021) |
| " Except one woman in the myoinositol group, all women provided glycaemia data throughout their pregnancy." | 5.41 | Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial. ( Balani, S; Bhatla, N; Kachhawa, G; Kulshrestha, V; Kumari, R; Sharma, JB; Vanamail, P, 2021) |
| "To verify whether myo-inositol plus α-lactalbumin may reduce insulin resistance and excessive fetal growth in women with gestational diabetes mellitus." | 5.41 | Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. ( Corrado, F; D'Anna, R; Di Benedetto, A; Giunta, L; Gullo, G; Loddo, S, 2021) |
| "Treatment of poor responders with myo-inositol from one month before starting ICSI cycle continuing until ovulation trigger can improve fertilization rate and embryo quality, and may enhance the cumulative pregnancy rate in poor responders." | 5.34 | Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial. ( Azizi, E; Ghodssi-Ghassemabadi, R; Hashemi, T; Hosseini, S; Nazari, L; Saharkhiz, N; Salehpour, S, 2020) |
| "This trial will provide evidence for the effectiveness of myo-inositol supplementation during pregnancy in reducing the incidence of gestational diabetes mellitus." | 5.34 | Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. ( Anastasiou, E; Antsaklis, P; Asimakopoulos, G; Daskalakis, G; Kallergi, A; Loutradis, D; Pergialiotis, V; Sindos, M; Theodora, M; Vogiatzi, E, 2020) |
| "The present study was planned to evaluate the benefit of synergetic effect of Metformin plus Myo-inositol versus Metformin alone in infertile polycystic ovarian syndrome (PCOS) women undergoing ovulation induction." | 5.30 | Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. ( Agrawal, A; Kachhawa, G; Khadgawat, R; Kriplani, A; Mahey, R; Vanamail, P, 2019) |
| "The purpose is a comparison of effectiveness of myo-inositol and metformin in infertile women with polycystic ovary syndrome (PCOS) treated with letrozole." | 5.30 | The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. ( Bazarganipour, F; Kutenaee, MA; Pourghasem, S; Taghavi, SA, 2019) |
| "Myo-inositol (MI), successfully used in polycystic ovary syndrome (PCOS), was administered with α-LA to exploit its action of favouring the passage of other molecules through biological barriers, and also considering its anti-inflammatory effect." | 5.27 | Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. ( Buonomo, G; Calcagno, M; Montanino Oliva, M; Unfer, V, 2018) |
| " The aim of the study is to compare the effect of different dosages of inositol stereoisomers supplementation on insulin resistance levels and several maternal-fetal outcomes in GDM women." | 5.27 | Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. ( Celentano, C; Di Nicola, M; Di Vieste, G; Franzago, M; Fraticelli, F; Liberati, M; Pintaudi, B; Vitacolonna, E; Zecca, IA, 2018) |
| "Commencing an inositol combination in early pregnancy did not prevent GDM in women with a family history of diabetes." | 5.24 | The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. ( Daly, N; Daly, S; Farren, M; Kinsley, B; McKeating, A; Turner, MJ, 2017) |
| "It was previously shown that higher concentrations of myo-inositol in human follicular fluid improve oocyte and embryo quality, whereas D-chiro-inositol seems to worsen oocyte quality and ovarian response in polycystic ovary syndrome patients." | 5.24 | Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality? ( Goudakou, M; Monastra, G; Pavlidou, T; Prapas, N; Ravanos, K, 2017) |
| "Objectıve: The aim of the study is to investigate the effect of myo-inositol (MYO) on pregnancy rates of patients diagnosed with polycystic ovary syndrome (PCOS) who undergone controlled ovulation induction and intrauterine insemination (IUI)." | 5.24 | Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. ( Çağlıyan, E; Emekçi Özay, Ö; Gülekli, B; Okyay, RE; Özay, AC, 2017) |
| " Among PCOS women undergoing assisted reproductive technology, treatment based on myo-inositol and high doses of D-chiro-inositol has been shown to increase pregnancy rate and number of live births, reduce ovarian hyperstimulation syndrome and improve oocyte quality." | 5.22 | Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants. ( Losa, F; Mendoza, N; Palacios, S, 2022) |
| "There is growing interest in the potential role of different stereoisomers of inositol or their combination as well as probiotics supplementation in healthy glucose metabolism during pregnancy and in promoting offspring health." | 5.22 | Inositols, Probiotics, and Gestational Diabetes: Clinical and Epigenetic Aspects. ( Franzago, M; Masulli, M; Palmisano, L; Stuppia, L; Vitacolonna, E, 2022) |
| "This study was aimed at assessing the efficacy and safety of inositol nutritional supplementation during pregnancy for the prevention of GDM." | 5.22 | Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Wei, J; Yan, J; Yang, H, 2022) |
| "To date, the involvement of α-Lactalbumin (α-LA) in the management of polycystic ovary syndrome (PCOS) refers to its ability to improve intestinal absorption of natural molecules like inositols, overcoming the inositol resistance." | 5.22 | Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome. ( Artale, S; Basciani, S; Bizzarri, M; Cardinale, V; Lepore, E; Nordio, M; Unfer, V, 2022) |
| "To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women." | 5.22 | Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A, 2016) |
| "Although peri-conceptional folic acid (FA) supplementation can prevent a proportion of neural tube defects (NTD), there is increasing evidence that many NTD are FA non-responsive." | 5.22 | Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. ( Burren, K; Chitty, LS; Copp, AJ; Gay, V; Greene, ND; Leung, KY; Mills, K, 2016) |
| "The aim of the present study is to evaluate the effectiveness of myo-inositol alone or in combination with clomiphene citrate for (1) induction of ovulation and (2) pregnancy rate in anovulatory women with PCOS and proven insulin resistance." | 5.20 | Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. ( Carlomagno, G; Gateva, A; Genazzani, AD; Kamenov, Z; Kolarov, G, 2015) |
| "In an open-label, randomized trial, myo-inositol (2 g plus 200 micrograms folic acid twice a day) or placebo (200 micrograms folic acid twice a day) was administered from the first trimester to delivery in pregnant obese women (prepregnancy body mass index 30 or greater." | 5.20 | Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial. ( Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Interdonato, ML; Neri, I; Petrella, E; Pintaudi, B; Santamaria, A; Scilipoti, A, 2015) |
| "Polycystic ovary syndrome (PCOS) women undergoing IVF-ET were treated with myo-inositol combined with D-chiro-inositol in the physiological ratio (1." | 5.17 | The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. ( Bevilacqua, A; Colazingari, S; Najjar, R; Treglia, M, 2013) |
| "Assessment of oocyte/embryo quality and pregnancy rates in 149 patients divided, according to a controlled randomized pattern, into two groups: study group 1 treated with folic acid and inositol and control group 2 treated with folic acid alone." | 5.17 | Inositol: effects on oocyte quality in patients undergoing ICSI. An open study. ( Brusco, GF; Mariani, M, 2013) |
| "To test the hypothesis that dietary myo-inositol may improve insulin resistance and the development of gestational diabetes mellitus (GDM) in women at high risk of this disorder." | 5.17 | Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. ( Celentano, C; D'Angelo, M; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2013) |
| "To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes." | 5.15 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giordano, D; Pintaudi, B; Santamaria, A, 2011) |
| "In the present study, we aim to evaluate the pregnancy outcomes after the administration of myo-inositol combined with melatonin in women who failed to conceive in previous in vitro fertilization (IVF) cycles due to poor oocyte quality." | 5.15 | Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. ( Buffo, S; Raffone, E; Rizzo, P; Unfer, V, 2011) |
| "The aim of this study was to compare the effectiveness of myo-inositol (MYO) and metformin, in monotherapy or in association with recombinant follicle stimulating hormone (r-FSH), in the treatment of menstrual irregularities, chronic anovulation, and female infertility in patients with polycystic ovary syndrome (PCOS)." | 5.14 | Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. ( Benedetto, V; Raffone, E; Rizzo, P, 2010) |
| "To determine the effects of myo-inositol on oocyte quality in polycystic ovary syndrome (PCOS) patients undergoing intracytoplasmic sperm injection (ICSI) cycles." | 5.14 | Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. ( Baillargeon, JP; De Santis, L; Fusi, F; Occhi, F; Papaleo, E; Unfer, V, 2009) |
| "Inositol supplementation decreases blood glucose through an improvement in insulin sensitivity that is independent of weight." | 5.01 | Effects of inositol on glucose homeostasis: Systematic review and meta-analysis of randomized controlled trials. ( Corcoy, R; Cuixart, G; Gonçalves, A; Miñambres, I, 2019) |
| "The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM)." | 4.98 | The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. ( Gateva, A; Kamenov, Z; Unfer, V, 2018) |
| "Introduction The use of 2 × 2000 mg myo-inositol +2 × 200 μg folic acid per day is a safe and promising tool in the effective improvement of symptoms and infertility for patients with polycystic ovary syndrome (PCOS)." | 4.98 | Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. ( Druckman, R; Lesoine, B; Regidor, PA; Schindler, AE, 2018) |
| " Insulin-sensitising agents such as metformin may be effective in treating PCOS-related anovulation." | 4.95 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Morley, LC; Norman, RJ; Tang, T; Yasmin, E, 2017) |
| " Myoinositol supplement was associated with significantly improved clinical pregnancy rate [95% confidence interval (CI), 1." | 4.95 | Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. ( Li, S; Lin, D; Lin, Y; Song, J; Sun, Y; Zhang, Y; Zheng, X, 2017) |
| " Maternal periconceptional supplementation with folic acid significantly reduces the risk of an NTD-affected pregnancy, but does not prevent all NTDs, and "folic acid non-responsive" NTDs continue to occur." | 4.95 | Inositol, neural tube closure and the prevention of neural tube defects. ( Copp, AJ; Greene, ND; Leung, KY, 2017) |
| "Although inositol dietary deficiency in the general population has not been demonstrated at the serum level, several findings are emerging regarding the impact of inositol supplementation in periconceptional period and in early phases of pregnancy." | 4.93 | Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications. ( Abdulrahim, B; Borgato, S; Gizzo, S; Noventa, M; Quaranta, M; Vitagliano, A, 2016) |
| "Evidence from four trials of antenatal dietary supplementation with myo-inositol during pregnancy shows a potential benefit for reducing the incidence of gestational diabetes." | 4.91 | Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. ( Alsweiler, J; Brown, J; Crawford, TJ; Crowther, CA, 2015) |
| "In agreement with the previous review, metformin was associated with improved clinical pregnancy but there was no evidence that metformin improves live birth rates whether it is used alone or in combination with clomiphene, or when compared with clomiphene." | 4.88 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Lord, JM; Norman, RJ; Tang, T; Yasmin, E, 2012) |
| " In particular, two natural molecules have been shown to exert beneficial effects on fertility, pregnancy wellness and embryo development: myo-inositol and melatonin, whose requirements increase during pregnancy." | 4.87 | Contribution of myo-inositol and melatonin to human reproduction. ( Carlomagno, G; Chiu, TT; Nordio, M; Unfer, V, 2011) |
| "In agreement with the previous review, metformin is still of benefit in improving clinical pregnancy and ovulation rates." | 4.86 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. ( Balen, AH; Lord, JM; Norman, RJ; Tang, T; Yasmin, E, 2010) |
| "Neural tube defects can be prevented by folic acid, although the mechanism of this action is unclear." | 4.80 | Prevention of neural tube defects: vitamins, enzymes and genes. ( Copp, AJ, 1998) |
| "Inositol is closely related to the occurrence of neural tube defects (NTDs)." | 4.31 | Genetic Effects of ITPK1 Polymorphisms on the Risk of Neural Tube Defects: a Population-Based Study. ( Guan, Z; Li, S; Liang, Y; Wang, J; Wang, X; Yang, A; Zhu, Z, 2023) |
| "Accumulating evidence suggests that oral supplementation with myo-Inositol (myo-Ins) is able to reduce the amount of gonadotropins and days of controlled ovarian hyperstimulation (COS) necessary to achieve adequate oocyte maturation in assisted reproduction technology (ART) protocols, particularly in women affected by polycystic ovary syndrome (PCOS)." | 4.31 | A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System. ( Aragona, C; Beresniak, A; Chiantera, V; Forte, G; Laganà, AS; Oliva, MM; Russo, M; Unfer, V, 2023) |
| "Maternal hyperglycemia is associated with disrupted transplacental arachidonic acid (AA) supply and eicosanoid synthesis, which contribute to adverse pregnancy outcomes." | 4.12 | Myo-Inositol Moderates Glucose-Induced Effects on Human Placental ( Bendt, AK; Cazenave-Gassiot, A; Chan, SY; Cracknell-Hazra, VKB; Godfrey, KM; Lewis, RM; Patmanathan, SN; Pillai, RA; Selvam, P; Sharma, N; Watkins, OC; Wenk, MR; Yong, HEJ, 2022) |
| "The aim of this work was to evaluate the effect of a comprehensive method of pre-pregnancy pre-treatment which includes a vitamin complex with inositol and vitamin D3, on the levels of pituitary and ovarian hormones in women with infertility against the background of polycystic ovary syndrome." | 4.12 | Hormonal profile in women with infertility against the background of polycystic ovary syndrome depending on the type of pre-pregnancy pre-treatment. ( Halnykina, S; Khmil Doswald, A; Khmil, M; Khmil, S, 2022) |
| "Supplementation with myo-inositol during the periconceptional period of pregnancy may ameliorate the recurrence risk of having a fetus affected by a neural tube defect (NTD; e." | 4.02 | Maternal Inositol Status and Neural Tube Defects: A Role for the Human Yolk Sac in Embryonic Inositol Delivery? ( Copp, AJ; D'Souza, SW; Glazier, JD; Greene, NDE, 2021) |
| "Myo-inositol supplementation at physiological doses during lactation improves metabolic health and prevents the programmed trend to develop insulin resistance and hypertriglyceridemia in male rats acquired by inadequate fetal nutrition and exacerbated by a diabetogenic diet in adulthood." | 4.02 | Sex-Specific Effects of Myo-Inositol Ingested During Lactation in the Improvement of Metabolic Health in Adult Rats. ( Castillo, P; Núñez, P; Otero, D; Palou, A; Palou, M; Picó, C, 2021) |
| "Inositols (INOs) supplementation during pregnancy, specifically the combination of myo-inositol (MI) and D-chiro-inositol (DCI), has been reported to improve vascular parameters in women with gestational diabetes mellitus." | 3.91 | Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. ( Alrais, M; Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Refuerzo, JS; Sibai, BM; Tamayo, EH, 2019) |
| "Compared to nonpregnant women, women with normal pregnancy and preeclampsia had lower levels of the cerebral osmolytes, myo-inositol, choline and creatine (P = 0." | 3.88 | Cerebral Osmolytes and Plasma Osmolality in Pregnancy and Preeclampsia: A Proton Magnetic Resonance Spectroscopy Study. ( Bergman, L; Larsson, A; Nelander, M; Sundström-Poromaa, I; Weis, J; Wikström, AK; Wikström, J, 2018) |
| "Myo-inositol treatment in early pregnancy is associated with a reduction in the rate of gestational diabetes mellitus and in the risk of preterm birth and macrosomia in women who are at risk for gestational diabetes mellitus." | 3.88 | Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. ( Alibrandi, A; Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Pintaudi, B; Santamaria, A, 2018) |
| "Authors would like to demonstrate the beneficial effect of myo-inositol supplementation in a pregnant woman with insulin-dependent type 2 diabetes mellitus and polycystic ovary syndrome." | 3.85 | [The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome]. ( Kun, A; Tornóczky, J, 2017) |
| "Our study aims to demonstrate that the use in the preconceptional period until the 24th week of pregnancy of inositol and folic acid, first of all, preserves the product of conception from neural tube defects (NTDs) and then, thanks to inositol supplementation, it possibly counteracts and prevents the onset of maternal gestational diabetes (GDM)." | 3.85 | Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. ( Allegretti, A; Benedetto, M; Capalbo, A; D'Apice, MR; Dell'Edera, D; Epifania, AA; Lupo, MG; Sarlo, F; Simone, F, 2017) |
| "Myoinositol and D-chiroinositol improve insulin resistance in women with obesity and gestational diabetes and in postmenopausal women with metabolic syndrome." | 3.83 | The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. ( Blackwell, SC; Facchinetti, F; Ferrari, F; Longo, M; Ontiveros, AE; Refuerzo, JS; Roberts, RP; Saade, MM; Sibai, BM, 2016) |
| "Myo-inositol (MI) deficiency is associated with an increased risk for neural tube defects (NTDs), mental disorders and metabolic diseases." | 3.83 | Quantification of plasma myo-inositol using gas chromatography-mass spectrometry. ( Guo, J; Niu, B; Shi, Y; Wang, J; Xu, C; Zhang, F; Zhang, T; Zhong, R, 2016) |
| "In recent years, interest has been focused to the study of the two major inositol stereoisomers: myo-inositol (MI) and d-chiro-inositol (DCI), because of their involvement, as second messengers of insulin, in several insulin-dependent processes, such as metabolic syndrome and polycystic ovary syndrome." | 3.81 | Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. ( Benvenga, S; Bevilacqua, A; Bizzarri, M; Carlomagno, G; Cavalli, P; Chiu, TT; D'Anna, R; Devroey, P; Di Renzo, GC; Facchinetti, F; Gerli, S; Hod, M; Kamenov, ZA; Lanzone, A; Oliva, MM; Soulage, C, 2015) |
| "To evaluate retrospectively the prevalence of gestational diabetes (GD) in pregnancies obtained with myo-inositol administration in women with polycystic ovary syndrome." | 3.78 | Myo-inositol may prevent gestational diabetes in PCOS women. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Benedetto, V; Interdonato, ML; Raffone, E; Rizzo, P, 2012) |
| "It is concluded that folate and myoinositol initiated early in mouse pregnancy can restore NMM-II expression, permit normal placentation/embryogenesis, and prevent IUGR induced by alcohol, lithium, and homocysteine." | 3.78 | Effects of alcohol, lithium, and homocysteine on nonmuscle myosin-II in the mouse placenta and human trophoblasts. ( Acharya, G; Brinez, P; Han, M; Huhta, JC; Linask, KK; Neves, AL; Serrano, M, 2012) |
| "Our findings suggest that the addition of myo-inositol to folic acid in non PCOS-patients undergoing multiple follicular stimulation for in-vitro fertilization may reduce the numbers of mature oocytes and the dosage of rFSH whilst maintaining clinical pregnancy rate." | 3.78 | Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. ( Carfagna, P; Caserta, D; Lisi, F; Lisi, R; Manna, C; Marci, R; Moscarini, M; Oliva, MM; Poverini, R; Rago, R; Raparelli, V; Vaquero, E, 2012) |
| "In an attempt to evaluate the role of inositol supplementation in insulin-resistant patients with polycystic ovary syndrome (PCOS), undergoing gonadotropin ovulation induction using the low-dose step-down regimen, we conducted a prospective longitudinal study comparing the stimulation characteristics of 15 patients treated with inositol, to a cohort, matched by age and body mass index (BMI), without inositol." | 3.77 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. ( De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Orvieto, R, 2011) |
| "Neural tube defects (NTDs), most commonly spina bifida and anencephaly, can be prevented with periconceptional intake of folic acid in about 70% of cases." | 3.77 | Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. ( Cavalli, P; Grosso, E; Poggiani, C; Tonni, G, 2011) |
| "To determine the blood concentrations of myo-inositol, glucose and zinc before, during and after normal pregnancy." | 3.73 | Myo-inositol, glucose and zinc concentrations determined in the preconceptional period, during and after pregnancy. ( Groenen, PM; Merkus, HM; Peer, PG; Roes, EM; Steegers, EA; Steegers-Theunissen, RP, 2006) |
| " In the spina bifida group, amniotic fluid myo-inositol, glucose and zinc concentrations gradually declined throughout pregnancy." | 3.72 | Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls? ( Groenen, PM; Janssen, FS; Merkus, JM; Steegers-Theunissen, RP; Tuerlings, JH; Wevers, RA, 2003) |
| "To investigate myo-inositol, glucose and zinc status in mothers and their infants on cleft lip with or without cleft palate risk (CLP)." | 3.72 | Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study. ( Brussel, W; Krapels, IP; Rooij, IA; Spauwen, PH; Steegers-Theunissen, RP; Wevers, RA; Zielhuis, GA, 2004) |
| "Among mouse genetic mutants that develop neural tube defects (NTDs), some respond to folic acid administration during early pregnancy, whereas NTDs in other mutants are not prevented." | 3.71 | D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. ( Allan, G; Cogram, P; Copp, AJ; Greene, ND; Tesh, J; Tesh, S; Wade, A, 2002) |
| " The present experiment was designed to determine: 1) if hyperglycemia-induced membrane injury is associated with intracellular and/or extracellular lipid disturbances; 2) if supplemental myo-inositol therapy prevents hyperglycemia-induced embryopathy; 3) if a correlation exists between dietary myo-inositol, serum and tissue levels of myo-inositol, and conceptus development; and 4) the cellular content of arachidonic acid following myo-inositol supplementation." | 3.70 | Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. ( Borenstein, M; Khandelwal, M; Reece, EA; Wu, YK, 1998) |
| "Lens fiber swelling and related cataractous outgrowth positively correlated to the degree of lens bSMIT gene expression and intralenticular myo-inositol content." | 3.70 | A transgenic animal model of osmotic cataract. Part 1: over-expression of bovine Na+/myo-inositol cotransporter in lens fibers. ( Cammarata, PR; Chen, G; Kuszak, JR; Reeves, RE; Robinson, ML; Singh, I; Zhou, C, 1999) |
| " It has been reported that a substantial proportion of NTD in humans can be prevented by folic acid (FA) supplementation prior to conception and during the first months of pregnancy, and myo-inositol (MI) was shown to reduce the incidence of NTD in curly tail mice which are not prevented by FA." | 3.70 | Folic acid supplementation of pregnant mice suppresses heat-induced neural tube defects in the offspring. ( Shin, JH; Shiota, K, 1999) |
| "Clinical trials demonstrate that up to 70% of neural tube defects (NTDs) can be prevented by folic acid supplementation in early pregnancy, whereas the remaining NTDs are resistant to folate." | 3.69 | Inositol prevents folate-resistant neural tube defects in the mouse. ( Copp, AJ; Greene, ND, 1997) |
| " The current investigation was undertaken to assess the use of dietary myo-inositol supplementation as a pharmacologic prophylaxis to obviate the teratogenic effects of hyperglycemia in an in vivo study." | 3.69 | Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. ( Borenstein, M; Khandelwal, M; Reece, EA; Wu, YK, 1997) |
| "Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of inositol trisphosphate (the putative second-messenger for oxytocin-stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy." | 3.68 | Oxytocin-stimulated inositol phosphate turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins. ( Bazer, FW; Davis, M; Mirando, MA; Ott, TL; Vallet, JL, 1990) |
| "We have shown that myo-inositol in the cultured rat embryo is diminished whenever malformations are induced by hyperglycemia and that the malformations and reductions of tissue myo-inositol content are not corrected by aldose reductase inhibitors." | 3.68 | Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. ( Freinkel, N; Garcia-Palmer, FJ; Weigensberg, MJ, 1990) |
| "Although gestational diabetes mellitus (GDM) has several short- and long-term adverse effects on the mother and the offspring, no medicine is generally prescribed to prevent GDM." | 3.01 | Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Ács, N; Greff, D; Hegyi, P; Horváth, EM; Nyirády, P; Park, S; Szinte, J; Váncsa, S; Váradi, A; Várbíró, S, 2023) |
| "Myo-inositol is a nutrient that enhances cellular glucose uptake." | 2.84 | Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial. ( Baker, PN; Chan, SY; Chong, YS; Cutfield, W; Godfrey, KM, 2017) |
| "Pregnancy is similarly characterized by substantial and complex changes in glycemic and lipidomic regulation as part of maternal adaptation and is also associated with physiological alterations in inositol processing." | 2.82 | A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. ( Chan, SY; Sharma, N; Watkins, OC; Yong, HEJ, 2022) |
| "Myo-inositol is a simple and safe treatment that is capable of restoring spontaneous ovarian activity and consequently fertility in most patients with PCOS." | 2.73 | Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. ( Baillargeon, JP; Brigante, C; Cino, I; De Santis, L; Ferrari, A; Fusi, F; Marelli, G; Papaleo, E; Redaelli, A; Unfer, V, 2007) |
| "Human pregnancy is a sequence of events finely tuned by several molecular interactions that come with a new birth." | 2.72 | Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth. ( Forte, G; Laganà, AS; Montanino Oliva, M; Russo, M; Unfer, V, 2021) |
| "The prevalence of gestational diabetes mellitus (GDM) is increasing, with approximately 15% of pregnant women affected worldwide, varying by country, ethnicity and diagnostic thresholds." | 2.66 | Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. ( Alsweiler, J; Brown, S; Crowther, CA; Griffith, RJ; Middleton, P; Moore, AE; Shepherd, E, 2020) |
| "Pregnancy is characterized by a physiologic increase in insulin resistance, which, associated with increased oxidative stress and inflammations, could induce alterations of glucose metabolism and diabetes." | 2.61 | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. ( Baldassarre, MPA; Bucci, I; Carlucci, MA; Consoli, A; Formoso, G; Ginestra, F, 2019) |
| "Myo-inositol is related to lower incidence of GDM, as well as fasting, 1h, and 2h OGTT value, in pregnant women with high risk of this condition." | 2.58 | Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. ( Guo, S; Guo, X; Li, Z; Miao, Z; Zhang, H, 2018) |
| "Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women." | 2.53 | Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus. ( Celentano, C; Liberati, M; Matarrelli, B; Mattei, PA; Pavone, G; Vitacolonna, E, 2016) |
| "The rise in gestational diabetes (GDM), defined as first onset or diagnosis of diabetes in pregnancy, is a global problem." | 2.52 | Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies. ( Chamillard, M; Hitman, GA; Khan, KS; Rogozińska, E; Thangaratinam, S, 2015) |
| "Inositol is a cyclic sugar alcohol which occurs naturally in a variety of stereoisomers, the most common of which is myo-inositol." | 2.49 | Myoinositol: a new marker of intrauterine growth restriction? ( Dessì, A; Fanos, V, 2013) |
| "Inositol has been reported to be effective in treating central nervous system disorders such as depression, Alzheimer's disease, panic disorder, and obsessive-compulsive disorder." | 2.40 | Inositol--clinical applications for exogenous use. ( Colodny, L; Hoffman, RL, 1998) |
| "The severe intestinal lipodystrophy that develops in female gerbils consuming inositol-deficient diets is likely mediated by a reduced synthesis of PI and the associated impairment of chylomicron assembly and secretion." | 2.37 | Metabolism and function of myo-inositol and inositol phospholipids. ( Holub, BJ, 1986) |
| "The incidence rate of birth defects was 3." | 1.56 | The Effects of Inositol Metabolism in Pregnant Women on Offspring in the North and South of China. ( Cui, M; Guan, Z; Guo, J; Li, S; Niu, B; Qin, J; Wang, J; Wang, X; Yue, H; Zhu, Z, 2020) |
| "Obesity is becoming pandemic and is associated with impaired reproductive potential." | 1.56 | Effects of α-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study. ( Anelli, GM; Cetin, I; Lisso, F; Mandò, C; Marzorati, A; Novielli, C; Oneta, M; Parrilla, B; Savasi, VM, 2020) |
| "Myo-inositol supplementation prevents gestational diabetes (GDM) in women at risk and reduces insulin resistance in women with GDM." | 1.48 | Effects of myo-inositol on glucose variability in women with gestational diabetes. ( Corrado, F; D'Anna, R; Di Benedetto, A; Di Vieste, G; Giunta, L; Lucisano, G; Pintaudi, B, 2018) |
| "The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling." | 1.43 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. ( Koos, B; Markovic, D; Murphy, A; Ostlund, R; Shamshirsaz, A, 2016) |
| "Myoinositol is a promising supplement that may represent the first GDM-risk modifier that could be implemented on a population-level." | 1.43 | The Potential Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus. ( Froehlich, RJ; Werner, EF, 2016) |
| "Myo-inositol (Myo-ins) is a marker of neuroglial cells, being present in the astrocytes of brain tissue, but also functions as an osmolyte." | 1.39 | Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study. ( Allsop, JM; Damodaram, MS; Kumar, S; Mcguinness, A; Patel, A; Rutherford, MA; Story, L; Supramaniam, V; Wylezinska, M, 2013) |
| "Valproic acid (VPA) is an anticonvulsant drug that is widely used therapeutically for a variety of neurological conditions." | 1.33 | Myo-inositol enhances teratogenicity of valproic acid in the mouse. ( Finnell, RH; Giavini, E; Massa, V; Wlodarczyk, B, 2006) |
| " Dose-response studies disclosed that incremental increases in [3H]InsP1 (129-420%) are observed over a concentration range of 10-1,000 nM." | 1.29 | Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis? ( Metzger, BE; Strieleman, PJ, 1993) |
| "Myo-inositol was found dominating the spectra at birth (12 mmoles/kg), while choline is responsible for the strongest peak in older infants (2." | 1.29 | Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. ( Ernst, T; Kreis, R; Ross, BD, 1993) |
| "Pretreatment with indomethacin prevented these effects of T3." | 1.28 | Evidence for direct non-genomic effects of triiodothyronine on bone rudiments in rats: stimulation of the inositol phosphate second messenger system. ( Lakatos, P; Stern, PH, 1991) |
| "Myoinositol concentration was studied in serum of 65 neonates and their mothers at the time of birth, in samples of various types of feedings for infants, and in serial serum samples of 15 premature infants receiving human milk, formulas for infants, or parenteral nutrition over a 3-wk period." | 1.28 | Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. ( Baker, L; Chiavacci, R; Corcoran, L; Egler, J; Pereira, GR, 1990) |
| "Myo-inositol is a necessary component of the phospholipid phosphatidyl-inositol, which is an important membrane constituent." | 1.27 | Inositol as a lipotropic agent in dairy cattle diets. ( Emery, RS; Gerloff, BJ; Herdt, TH; Wells, WW, 1984) |
| "Galactitol is a component of normal amniotic fluid with a mean concentration of 0." | 1.27 | Stable isotope dilution analysis of galactitol in amniotic fluid: an accurate approach to the prenatal diagnosis of galactosemia. ( Jakobs, C; Nyhan, WL; Sweetman, L; Warner, TG, 1984) |
| "Inositol was found to inhibit glycerolphosphate phosphatidyltransferase in the microsomal fraction but not in the mitochondrial fraction derived from the type II cells, indicating that the competition between phosphatidylglycerol and phosphatidylinositol synthesis for CDP diacylglycerol takes place in the endoplasmic reticulum." | 1.27 | Regulation and location of phosphatidylglycerol and phosphatidylinositol synthesis in type II cells isolated from fetal rat lung. ( Batenburg, JJ; Klazinga, W; van Golde, LM, 1985) |
| "This is a major cause of respiratory failure in RDS." | 1.26 | Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure. ( Hallman, M, 1982) |
| "2." | 1.26 | myo-inositol in the reproductive tract of the female rat. ( Lewin, LM; Melmed, S; Weiss, M; Yannai, Y, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 62 (20.46) | 18.7374 |
| 1990's | 43 (14.19) | 18.2507 |
| 2000's | 30 (9.90) | 29.6817 |
| 2010's | 105 (34.65) | 24.3611 |
| 2020's | 63 (20.79) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, N | 4 |
| Watkins, OC | 5 |
| Chu, AHY | 3 |
| Cutfield, W | 3 |
| Godfrey, KM | 7 |
| Yong, HEJ | 3 |
| Chan, SY | 10 |
| Castillo, P | 2 |
| Palou, M | 2 |
| Yau-Qiu, ZX | 1 |
| Rodríguez, AM | 1 |
| Palou, A | 2 |
| Picó, C | 2 |
| Rajasekaran, K | 1 |
| Malhotra, N | 1 |
| Mahey, R | 3 |
| Khadgawat, R | 3 |
| Kalaivani, M | 1 |
| Dinicola, S | 1 |
| Unfer, V | 15 |
| Facchinetti, F | 10 |
| Soulage, CO | 2 |
| Greene, ND | 5 |
| Bizzarri, M | 5 |
| Laganà, AS | 4 |
| Bevilacqua, A | 4 |
| Pkhaladze, L | 1 |
| Benvenga, S | 2 |
| Stringaro, A | 1 |
| Barbaro, D | 1 |
| Appetecchia, M | 1 |
| Aragona, C | 3 |
| Bezerra Espinola, MS | 2 |
| Cantelmi, T | 1 |
| Cavalli, P | 7 |
| Chiu, TT | 5 |
| Copp, AJ | 9 |
| D'Anna, R | 15 |
| Dewailly, D | 2 |
| Di Lorenzo, C | 1 |
| Diamanti-Kandarakis, E | 1 |
| Hernández Marín, I | 1 |
| Hod, M | 6 |
| Kamenov, Z | 3 |
| Kandaraki, E | 2 |
| Monastra, G | 2 |
| Montanino Oliva, M | 4 |
| Nestler, JE | 2 |
| Nordio, M | 3 |
| Ozay, AC | 2 |
| Papalou, O | 1 |
| Porcaro, G | 1 |
| Prapas, N | 2 |
| Roseff, S | 1 |
| Vazquez-Levin, M | 1 |
| Vucenik, I | 1 |
| Wdowiak, A | 2 |
| Jackson, WM | 1 |
| Santos, HP | 1 |
| Hartwell, HJ | 1 |
| Gower, WA | 1 |
| Chhabra, D | 1 |
| Hagood, JS | 1 |
| Laughon, MM | 1 |
| Payton, A | 1 |
| Smeester, L | 1 |
| Roell, K | 1 |
| O'Shea, TM | 1 |
| Fry, RC | 1 |
| Mendoza, N | 2 |
| Losa, F | 1 |
| Palacios, S | 1 |
| Ibrahim, I | 1 |
| Abdullahi, H | 1 |
| Fagier, Y | 1 |
| Ortashi, O | 1 |
| Terrangera, A | 1 |
| Okunoye, G | 1 |
| DiNicolantonio, JJ | 1 |
| H O'Keefe, J | 1 |
| Amaefule, CE | 1 |
| Drymoussi, Z | 1 |
| Gonzalez Carreras, FJ | 1 |
| Pardo Llorente, MDC | 1 |
| Lanz, D | 1 |
| Dodds, J | 1 |
| Sweeney, L | 1 |
| Pizzo, E | 1 |
| Thomas, A | 1 |
| Heighway, J | 1 |
| Daru, J | 1 |
| Sobhy, S | 1 |
| Poston, L | 1 |
| Khalil, A | 1 |
| Myers, J | 1 |
| Harden, A | 1 |
| Hitman, G | 1 |
| Khan, KS | 2 |
| Zamora, J | 1 |
| Pérez, T | 1 |
| Huda, MSB | 1 |
| Thangaratinam, S | 3 |
| Condorelli, RA | 1 |
| Cannarella, R | 1 |
| Crafa, A | 1 |
| Barbagallo, F | 1 |
| Gusmano, C | 1 |
| Avola, O | 1 |
| Mongioì, LM | 1 |
| Basile, L | 1 |
| Calogero, AE | 1 |
| La Vignera, S | 1 |
| Bertran-Cobo, C | 1 |
| Wedderburn, CJ | 1 |
| Robertson, FC | 1 |
| Subramoney, S | 1 |
| Narr, KL | 1 |
| Joshi, SH | 1 |
| Roos, A | 1 |
| Rehman, AM | 1 |
| Hoffman, N | 1 |
| Zar, HJ | 1 |
| Stein, DJ | 1 |
| Donald, KA | 1 |
| Vitacolonna, E | 4 |
| Masulli, M | 1 |
| Palmisano, L | 1 |
| Stuppia, L | 1 |
| Franzago, M | 2 |
| Li, L | 1 |
| Fang, J | 1 |
| Tang, Q | 1 |
| Zhong, Y | 1 |
| Xu, C | 2 |
| Li, W | 1 |
| Wang, H | 1 |
| Hou, Y | 1 |
| Liu, Q | 1 |
| Liu, Z | 2 |
| Esmaeilzadeh, S | 2 |
| Ghadimi, R | 1 |
| Mashayekh-Amiri, S | 2 |
| Delavar, MA | 2 |
| Basirat, Z | 1 |
| Guarnotta, V | 1 |
| Cuva, G | 1 |
| Imbergamo, MP | 1 |
| Giordano, C | 1 |
| Wei, J | 1 |
| Yan, J | 1 |
| Yang, H | 1 |
| Cardinale, V | 1 |
| Lepore, E | 1 |
| Basciani, S | 1 |
| Artale, S | 1 |
| Cracknell-Hazra, VKB | 1 |
| Pillai, RA | 2 |
| Selvam, P | 3 |
| Patmanathan, SN | 1 |
| Cazenave-Gassiot, A | 1 |
| Bendt, AK | 1 |
| Lewis, RM | 3 |
| Wenk, MR | 1 |
| Unanyan, A | 1 |
| Pivazyan, L | 1 |
| Krylova, E | 1 |
| Eskin, A | 1 |
| Zakaryan, A | 1 |
| Sarkisova, A | 1 |
| Ishchenko, A | 1 |
| Guan, Z | 4 |
| Liang, Y | 1 |
| Zhu, Z | 2 |
| Yang, A | 1 |
| Li, S | 4 |
| Wang, X | 5 |
| Wang, J | 5 |
| Khmil, M | 1 |
| Khmil Doswald, A | 1 |
| Halnykina, S | 1 |
| Khmil, S | 1 |
| Barton, SJ | 2 |
| Loy, SL | 1 |
| Chang, HF | 2 |
| Titcombe, P | 1 |
| Wong, JT | 1 |
| Ebreo, M | 1 |
| Ong, J | 1 |
| Tan, KM | 1 |
| Nield, H | 2 |
| El-Heis, S | 2 |
| Kenealy, T | 2 |
| Chong, YS | 4 |
| Baker, PN | 5 |
| Cutfield, WS | 1 |
| Motuhifonua, SK | 1 |
| Lin, L | 1 |
| Alsweiler, J | 3 |
| Crawford, TJ | 2 |
| Crowther, CA | 3 |
| Nazirudeen, R | 1 |
| Sridhar, S | 1 |
| Priyanka, R | 1 |
| Sumathi, B | 1 |
| Natarajan, V | 1 |
| Subbiah, E | 1 |
| Raghavan, KS | 1 |
| Sangumani, J | 1 |
| Greff, D | 1 |
| Váncsa, S | 1 |
| Váradi, A | 1 |
| Szinte, J | 1 |
| Park, S | 1 |
| Hegyi, P | 1 |
| Nyirády, P | 1 |
| Ács, N | 1 |
| Horváth, EM | 1 |
| Várbíró, S | 1 |
| Beresniak, A | 1 |
| Russo, M | 2 |
| Forte, G | 2 |
| Oliva, MM | 3 |
| Chiantera, V | 1 |
| Factor, PA | 1 |
| Corpuz, H | 1 |
| Islam, MO | 2 |
| Appukuttan Pillai, R | 1 |
| Guardo, FD | 2 |
| Currò, JM | 1 |
| Valenti, G | 1 |
| Rossetti, P | 1 |
| Di Gregorio, LM | 1 |
| Conway, F | 1 |
| Chiofalo, B | 1 |
| Garzon, S | 1 |
| Bruni, S | 1 |
| Rizzo, G | 1 |
| Santamaria, A | 7 |
| Alibrandi, A | 2 |
| Corrado, F | 12 |
| DI Benedetto, A | 10 |
| Plows, JF | 2 |
| Ramos Nieves, JM | 1 |
| Budin, F | 2 |
| Mace, K | 2 |
| Reynolds, CM | 1 |
| Vickers, MH | 2 |
| Silva-Zolezzi, I | 3 |
| Stanley, JL | 2 |
| Sobota-Grzeszyk, A | 1 |
| Kuźmicki, M | 1 |
| Szamatowicz, J | 1 |
| Nazari, L | 1 |
| Salehpour, S | 1 |
| Hosseini, S | 1 |
| Saharkhiz, N | 1 |
| Azizi, E | 1 |
| Hashemi, T | 1 |
| Ghodssi-Ghassemabadi, R | 1 |
| Yue, H | 2 |
| Guo, J | 4 |
| Qin, J | 2 |
| Niu, B | 4 |
| Cui, M | 1 |
| Artini, PG | 1 |
| Obino, MER | 1 |
| Micelli, E | 1 |
| Malacarne, E | 1 |
| Vacca, C | 1 |
| Papini, F | 1 |
| Cela, V | 1 |
| Menichini, D | 1 |
| Alrais, M | 2 |
| Liu, C | 1 |
| Xia, Y | 1 |
| Blackwell, SC | 3 |
| Sibai, BM | 3 |
| Longo, M | 3 |
| Kısa, B | 1 |
| Sert, UY | 1 |
| Celik, HK | 1 |
| Candar, T | 1 |
| Erol Koç, EM | 1 |
| Taşcı, Y | 1 |
| Çağlar, GS | 1 |
| Buonomo, G | 2 |
| Carra, MC | 1 |
| Lippa, A | 1 |
| Lisi, F | 2 |
| Arishe, OO | 1 |
| Ebeigbe, AB | 1 |
| Webb, RC | 1 |
| Tint, MT | 1 |
| Wong, G | 1 |
| Yuan, WL | 1 |
| Tull, D | 1 |
| Nijagal, B | 1 |
| Narayana, VK | 1 |
| Meikle, PJ | 1 |
| Chang, KTE | 1 |
| Chi, C | 1 |
| Yap, FKP | 1 |
| Tan, KH | 1 |
| Shek, LP | 1 |
| Gluckman, PD | 1 |
| Lee, YS | 1 |
| Fortier, MV | 1 |
| Eriksson, JG | 1 |
| Karnani, N | 1 |
| Griffith, RJ | 1 |
| Moore, AE | 1 |
| Brown, S | 1 |
| Middleton, P | 1 |
| Shepherd, E | 1 |
| Asimakopoulos, G | 1 |
| Pergialiotis, V | 1 |
| Anastasiou, E | 1 |
| Antsaklis, P | 1 |
| Theodora, M | 1 |
| Vogiatzi, E | 1 |
| Kallergi, A | 1 |
| Sindos, M | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Monnard, I | 1 |
| Bénet, T | 1 |
| Jenni, R | 1 |
| Austin, S | 1 |
| Godin, JP | 1 |
| Palladino, E | 1 |
| Van Mieghem, T | 1 |
| Connor, KL | 1 |
| D'Souza, SW | 1 |
| Greene, NDE | 2 |
| Glazier, JD | 1 |
| Filip, M | 1 |
| Bakouei, F | 1 |
| Faramarzi, M | 1 |
| Prabhakar, P | 1 |
| Gupta, M | 1 |
| Kachhawa, G | 3 |
| Sharma, JB | 2 |
| Vanamail, P | 3 |
| Kumari, R | 2 |
| Bhatla, N | 2 |
| Luo, D | 1 |
| Lyu, J | 1 |
| Yang, Y | 1 |
| Gao, T | 1 |
| Liu, Y | 1 |
| Wang, F | 2 |
| Zhang, F | 2 |
| Zhang, T | 3 |
| Zhong, R | 2 |
| Vitale, SG | 1 |
| Caruso, S | 1 |
| Giunta, L | 3 |
| Cianci, A | 1 |
| Novielli, C | 1 |
| Anelli, GM | 1 |
| Lisso, F | 1 |
| Marzorati, A | 1 |
| Parrilla, B | 1 |
| Oneta, M | 1 |
| Savasi, VM | 1 |
| Cetin, I | 1 |
| Mandò, C | 1 |
| Merviel, P | 1 |
| James, P | 1 |
| Bouée, S | 1 |
| Le Guillou, M | 1 |
| Rince, C | 1 |
| Nachtergaele, C | 1 |
| Kerlan, V | 1 |
| Bertelli, M | 1 |
| Visconti, B | 1 |
| Otero, D | 1 |
| Núñez, P | 1 |
| Kulshrestha, V | 1 |
| Balani, S | 1 |
| Chan, KY | 1 |
| Wong, MMH | 1 |
| Pang, SSH | 1 |
| Lo, KKH | 1 |
| Mohammadi, S | 1 |
| Eini, F | 1 |
| Bazarganipour, F | 2 |
| Taghavi, SA | 2 |
| Kutenaee, MA | 2 |
| Loddo, S | 1 |
| Gullo, G | 1 |
| Wang, L | 1 |
| Cheng, H | 1 |
| Zheng, L | 2 |
| Baldassarre, MPA | 2 |
| Di Tomo, P | 1 |
| Centorame, G | 1 |
| Pandolfi, A | 1 |
| Di Pietro, N | 1 |
| Consoli, A | 2 |
| Formoso, G | 2 |
| Farren, M | 2 |
| Daly, N | 1 |
| McKeating, A | 1 |
| Kinsley, B | 1 |
| Turner, MJ | 2 |
| Daly, S | 2 |
| Kun, A | 1 |
| Tornóczky, J | 1 |
| Nas, K | 1 |
| Tűű, L | 1 |
| Rolland, AL | 1 |
| Peigné, M | 1 |
| Plouvier, P | 1 |
| Dumont, A | 1 |
| Catteau-Jonard, S | 1 |
| Korosi, T | 1 |
| Barta, C | 1 |
| Rokob, K | 1 |
| Torok, T | 1 |
| Costabile, L | 1 |
| Dell'Edera, D | 1 |
| Sarlo, F | 1 |
| Allegretti, A | 1 |
| Epifania, AA | 1 |
| Simone, F | 1 |
| Lupo, MG | 1 |
| Benedetto, M | 1 |
| D'Apice, MR | 1 |
| Capalbo, A | 1 |
| Özturan, A | 1 |
| Arslan, S | 1 |
| Kocaadam, B | 1 |
| Elibol, E | 1 |
| İmamoğlu, İ | 1 |
| Karadağ, MG | 1 |
| Pintaudi, B | 7 |
| Di Vieste, G | 4 |
| Morley, LC | 1 |
| Tang, T | 3 |
| Yasmin, E | 3 |
| Norman, RJ | 3 |
| Balen, AH | 3 |
| Ravanos, K | 1 |
| Pavlidou, T | 1 |
| Goudakou, M | 1 |
| Zheng, X | 2 |
| Lin, D | 1 |
| Zhang, Y | 2 |
| Lin, Y | 2 |
| Song, J | 2 |
| Sun, Y | 1 |
| Gateva, A | 2 |
| Guo, X | 1 |
| Guo, S | 1 |
| Miao, Z | 1 |
| Li, Z | 2 |
| Zhang, H | 2 |
| Lv, Y | 1 |
| Sun, L | 1 |
| Guo, W | 1 |
| Nelander, M | 1 |
| Wikström, AK | 1 |
| Weis, J | 1 |
| Bergman, L | 1 |
| Larsson, A | 1 |
| Sundström-Poromaa, I | 1 |
| Wikström, J | 1 |
| Regidor, PA | 1 |
| Schindler, AE | 1 |
| Lesoine, B | 1 |
| Druckman, R | 1 |
| Calcagno, M | 1 |
| Fraticelli, F | 1 |
| Celentano, C | 3 |
| Zecca, IA | 1 |
| Liberati, M | 3 |
| Di Nicola, M | 1 |
| Miñambres, I | 1 |
| Cuixart, G | 1 |
| Gonçalves, A | 1 |
| Corcoy, R | 1 |
| Dragotto, J | 1 |
| Giuliani, A | 1 |
| Lucisano, G | 1 |
| Canepa, P | 1 |
| Dal Lago, A | 1 |
| De Leo, C | 1 |
| Gallo, M | 1 |
| Rizzo, C | 1 |
| Licata, E | 1 |
| Anserini, P | 1 |
| Rago, R | 2 |
| Scaruffi, P | 1 |
| Cutler, DA | 1 |
| Shaw, AK | 1 |
| Pride, SM | 1 |
| Bedaiwy, MA | 1 |
| Cheung, AP | 1 |
| Tamayo, EH | 1 |
| Ferrari, F | 2 |
| Refuerzo, JS | 2 |
| Vitagliano, A | 2 |
| Saccone, G | 1 |
| Cosmi, E | 1 |
| Visentin, S | 1 |
| Dessole, F | 1 |
| Ambrosini, G | 1 |
| Berghella, V | 1 |
| Showell, MG | 1 |
| Mackenzie-Proctor, R | 1 |
| Jordan, V | 1 |
| Hodgson, R | 1 |
| Farquhar, C | 1 |
| Pundir, J | 1 |
| Charles, D | 1 |
| Sabatini, L | 1 |
| Hiam, D | 1 |
| Jitpiriyaroj, S | 1 |
| Teede, H | 1 |
| Coomarasamy, A | 1 |
| Moran, L | 1 |
| Agrawal, A | 1 |
| Kriplani, A | 1 |
| Pourghasem, S | 1 |
| Diaz-Ropero, MP | 1 |
| Aragon, M | 1 |
| Maldonado, V | 1 |
| Llaneza, P | 1 |
| Lorente, J | 1 |
| Mendoza-Tesarik, R | 1 |
| Maldonado-Lobon, J | 1 |
| Olivares, M | 1 |
| Fonolla, J | 1 |
| Ginestra, F | 1 |
| Carlucci, MA | 1 |
| Bucci, I | 1 |
| Di Nicuolo, F | 1 |
| D'Ippolito, S | 1 |
| Castellani, R | 1 |
| Rossi, ED | 1 |
| Masciullo, V | 1 |
| Specchia, M | 1 |
| Mariani, M | 2 |
| Pontecorvi, A | 1 |
| Scambia, G | 1 |
| Di Simone, N | 1 |
| Reyes-Muñoz, E | 1 |
| Ciebiera, M | 1 |
| Kahramanoglu, I | 1 |
| Sathyapalan, T | 1 |
| Lin, LT | 1 |
| Shah, M | 1 |
| Karaman, E | 1 |
| Fan, S | 1 |
| Zito, G | 1 |
| Noventa, M | 2 |
| Coustan, DR | 1 |
| Colazingari, S | 1 |
| Treglia, M | 1 |
| Najjar, R | 1 |
| Croze, ML | 1 |
| Fanos, V | 2 |
| Locci, E | 1 |
| Noto, A | 1 |
| Lazzarotto, T | 1 |
| Manzoni, P | 1 |
| Atzori, L | 1 |
| Lanari, M | 1 |
| Story, L | 1 |
| Damodaram, MS | 1 |
| Supramaniam, V | 1 |
| Allsop, JM | 1 |
| Mcguinness, A | 1 |
| Patel, A | 1 |
| Wylezinska, M | 1 |
| Kumar, S | 1 |
| Rutherford, MA | 1 |
| Dessì, A | 1 |
| Brusco, GF | 1 |
| Metges, CC | 1 |
| Görs, S | 1 |
| Lang, IS | 1 |
| Hammon, HM | 1 |
| Brüssow, KP | 1 |
| Weitzel, JM | 1 |
| Nürnberg, G | 1 |
| Rehfeldt, C | 1 |
| Otten, W | 1 |
| Li, G | 1 |
| Xie, Q | 1 |
| Han, X | 1 |
| Malvasi, A | 1 |
| Casciaro, F | 1 |
| Minervini, MM | 1 |
| Kosmas, I | 1 |
| Mynbaev, OA | 1 |
| Pacella, E | 1 |
| Monti Condesnitt, V | 1 |
| Creanza, A | 1 |
| Di Renzo, GC | 3 |
| Tinelli, A | 1 |
| Interdonato, ML | 4 |
| Baviera, G | 2 |
| Carlomagno, G | 7 |
| Costantino, D | 1 |
| Guaraldi, C | 1 |
| Kolarov, G | 1 |
| Genazzani, AD | 1 |
| Lee, GT | 1 |
| Price, MD | 1 |
| Mejia, CA | 1 |
| Galan, HL | 5 |
| Arroyo, JA | 3 |
| Rubino, P | 1 |
| Palini, S | 1 |
| Chigioni, S | 1 |
| Quagliariello, A | 1 |
| De Stefani, S | 1 |
| Baglioni, A | 1 |
| Bulletti, C | 1 |
| Rogozińska, E | 1 |
| Chamillard, M | 1 |
| Hitman, GA | 1 |
| Simmons, D | 1 |
| Caprio, F | 1 |
| D'Eufemia, MD | 1 |
| Trotta, C | 1 |
| Campitiello, MR | 1 |
| Ianniello, R | 1 |
| Mele, D | 1 |
| Colacurci, N | 1 |
| Quaranta, M | 1 |
| Borgato, S | 1 |
| Abdulrahim, B | 1 |
| Gizzo, S | 1 |
| Scilipoti, A | 2 |
| Petrella, E | 2 |
| Neri, I | 2 |
| Murphy, A | 1 |
| Shamshirsaz, A | 1 |
| Markovic, D | 1 |
| Ostlund, R | 1 |
| Koos, B | 1 |
| Li, Q | 1 |
| Leung, YO | 1 |
| Zhou, I | 1 |
| Ho, LC | 1 |
| Kong, W | 1 |
| Basil, P | 1 |
| Wei, R | 1 |
| Lam, S | 1 |
| Zhang, X | 1 |
| Law, AC | 1 |
| Chua, SE | 1 |
| Sham, PC | 1 |
| Wu, EX | 1 |
| McAlonan, GM | 1 |
| Dong, D | 1 |
| Reece, EA | 5 |
| Lin, X | 1 |
| Wu, Y | 1 |
| AriasVillela, N | 1 |
| Yang, P | 1 |
| Lanzone, A | 1 |
| Soulage, C | 1 |
| Kamenov, ZA | 1 |
| Gerli, S | 1 |
| Devroey, P | 1 |
| Lin, S | 1 |
| Pacchiarotti, A | 2 |
| Antonini, G | 1 |
| Alviggi, C | 1 |
| Cariati, F | 1 |
| Conforti, A | 1 |
| De Rosa, P | 1 |
| Vallone, R | 1 |
| Strina, I | 1 |
| Pivonello, R | 1 |
| De Placido, G | 1 |
| Brown, J | 1 |
| Leung, KY | 2 |
| Gay, V | 1 |
| Burren, K | 1 |
| Mills, K | 1 |
| Chitty, LS | 1 |
| Matarrelli, B | 2 |
| Mattei, PA | 2 |
| Pavone, G | 2 |
| Lubin, V | 1 |
| Shojai, R | 1 |
| Darmon, P | 1 |
| Cosson, E | 1 |
| Werner, EF | 1 |
| Froehlich, RJ | 1 |
| Ontiveros, AE | 1 |
| Roberts, RP | 1 |
| Saade, MM | 1 |
| Shi, Y | 1 |
| Adams Waldorf, KM | 1 |
| Stencel-Baerenwald, JE | 1 |
| Kapur, RP | 1 |
| Studholme, C | 1 |
| Boldenow, E | 1 |
| Vornhagen, J | 1 |
| Baldessari, A | 1 |
| Dighe, MK | 1 |
| Thiel, J | 1 |
| Merillat, S | 1 |
| Armistead, B | 1 |
| Tisoncik-Go, J | 1 |
| Green, RR | 1 |
| Davis, MA | 1 |
| Dewey, EC | 1 |
| Fairgrieve, MR | 1 |
| Gatenby, JC | 1 |
| Richards, T | 1 |
| Garden, GA | 1 |
| Diamond, MS | 1 |
| Juul, SE | 1 |
| Grant, RF | 1 |
| Kuller, L | 1 |
| Shaw, DW | 1 |
| Ogle, J | 1 |
| Gough, GM | 1 |
| Lee, W | 1 |
| English, C | 1 |
| Hevner, RF | 1 |
| Dobyns, WB | 1 |
| Gale, M | 1 |
| Rajagopal, L | 1 |
| Legro, RS | 1 |
| Andersson, RA | 1 |
| Mills, VJ | 1 |
| Davidge, ST | 1 |
| Emekçi Özay, Ö | 1 |
| Çağlıyan, E | 1 |
| Okyay, RE | 1 |
| Gülekli, B | 1 |
| McNamara, RK | 1 |
| Able, J | 1 |
| Jandacek, R | 1 |
| Rider, T | 1 |
| Tso, P | 1 |
| Lindquist, DM | 1 |
| Wentzel, P | 2 |
| Teng, C | 4 |
| Battaglia, FC | 6 |
| Lord, JM | 2 |
| Raffone, E | 5 |
| Rizzo, P | 5 |
| Benedetto, V | 2 |
| Regnault, TR | 1 |
| de Vrijer, B | 1 |
| Wilkening, RB | 1 |
| Morgante, G | 1 |
| Orvieto, R | 1 |
| Di Sabatino, A | 1 |
| Musacchio, MC | 1 |
| De Leo, V | 1 |
| Giordano, D | 2 |
| Buffo, S | 1 |
| Papaleo, E | 3 |
| Cittadini, E | 1 |
| Momozawa, K | 1 |
| Fukuda, Y | 1 |
| Tonni, G | 1 |
| Grosso, E | 1 |
| Poggiani, C | 1 |
| Di Benedetto, V | 1 |
| Garcia-Jones, P | 1 |
| Graham, A | 1 |
| Teng, CC | 1 |
| Staat, BC | 1 |
| Harwood, JE | 1 |
| Lee, G | 1 |
| Marconi, AM | 2 |
| Paolini, CL | 1 |
| Cheung, A | 1 |
| Han, M | 1 |
| Neves, AL | 1 |
| Serrano, M | 1 |
| Brinez, P | 1 |
| Huhta, JC | 1 |
| Acharya, G | 1 |
| Linask, KK | 1 |
| Berger-Kulemann, V | 1 |
| Brugger, PC | 1 |
| Pugash, D | 1 |
| Krssak, M | 1 |
| Weber, M | 1 |
| Wielandner, A | 1 |
| Prayer, D | 1 |
| Carfagna, P | 1 |
| Lisi, R | 1 |
| Poverini, R | 1 |
| Manna, C | 1 |
| Vaquero, E | 1 |
| Caserta, D | 1 |
| Raparelli, V | 1 |
| Marci, R | 1 |
| Moscarini, M | 1 |
| D'Angelo, M | 1 |
| Caruso, C | 1 |
| Cannata, ML | 1 |
| Cogram, P | 1 |
| Tesh, S | 1 |
| Tesh, J | 1 |
| Wade, A | 1 |
| Allan, G | 1 |
| Kok, RD | 2 |
| van den Berg, PP | 2 |
| van den Bergh, AJ | 1 |
| Nijland, R | 2 |
| Heerschap, A | 2 |
| Kreis, R | 2 |
| Hofmann, L | 1 |
| Kuhlmann, B | 1 |
| Boesch, C | 1 |
| Bossi, E | 1 |
| Hüppi, PS | 1 |
| Groenen, PM | 2 |
| Wevers, RA | 3 |
| Janssen, FS | 1 |
| Tuerlings, JH | 1 |
| Merkus, JM | 1 |
| Steegers-Theunissen, RP | 4 |
| Eriksson, UJ | 2 |
| Cederberg, J | 1 |
| Celik, O | 1 |
| Hascalik, S | 1 |
| BALESTRI, F | 1 |
| BONINO, A | 1 |
| PESCETTO, G | 1 |
| Ting, SB | 1 |
| Wilanowski, T | 1 |
| Auden, A | 1 |
| Hall, M | 1 |
| Voss, AK | 1 |
| Thomas, T | 1 |
| Parekh, V | 1 |
| Cunningham, JM | 1 |
| Jane, SM | 1 |
| Franke, B | 1 |
| Klootwijk, R | 1 |
| Lemmers, B | 1 |
| de Kovel, CG | 1 |
| Mariman, EC | 1 |
| Krapels, IP | 1 |
| Rooij, IA | 1 |
| Zielhuis, GA | 1 |
| Spauwen, PH | 1 |
| Brussel, W | 1 |
| Jauniaux, E | 1 |
| Hempstock, J | 1 |
| Burton, GJ | 1 |
| Shaw, GM | 1 |
| Carmichael, SL | 1 |
| Yang, W | 1 |
| Schaffer, DM | 1 |
| Gojnic, M | 1 |
| Pervulov, M | 1 |
| Roes, EM | 1 |
| Peer, PG | 1 |
| Merkus, HM | 1 |
| Steegers, EA | 1 |
| Brusati, V | 1 |
| Józwik, M | 2 |
| Paolini, C | 1 |
| Massa, V | 1 |
| Wlodarczyk, B | 1 |
| Giavini, E | 1 |
| Finnell, RH | 1 |
| Rillema, JA | 1 |
| Bell, CA | 1 |
| Baillargeon, JP | 2 |
| De Santis, L | 2 |
| Fusi, F | 2 |
| Brigante, C | 1 |
| Marelli, G | 1 |
| Cino, I | 1 |
| Redaelli, A | 1 |
| Ferrari, A | 1 |
| Tedoldi, S | 1 |
| Riboli, B | 1 |
| Shaw, G | 1 |
| Occhi, F | 1 |
| Wells, HJ | 1 |
| Wells, WW | 12 |
| Britton, HG | 1 |
| Huggett, AS | 1 |
| Nixon, DA | 2 |
| Gerloff, BJ | 3 |
| Herdt, TH | 3 |
| Emery, RS | 3 |
| Jakobs, C | 1 |
| Warner, TG | 1 |
| Sweetman, L | 1 |
| Nyhan, WL | 1 |
| Quirk, JG | 3 |
| Baumgarten, B | 1 |
| Bleasdale, JE | 4 |
| Derappe, C | 1 |
| Bauvy, C | 1 |
| Meyer, DM | 1 |
| Lemonnier, M | 1 |
| Lhermitte, M | 1 |
| Platzer, N | 1 |
| Hallman, M | 4 |
| Wermer, D | 1 |
| Epstein, BL | 1 |
| Gluck, L | 1 |
| Byun, SM | 1 |
| Jenness, R | 1 |
| Longmuir, KJ | 1 |
| Johnston, JM | 1 |
| Lewin, LM | 1 |
| Yannai, Y | 1 |
| Melmed, S | 1 |
| Weiss, M | 1 |
| Tyan, ML | 2 |
| Rhodes, PG | 2 |
| Cai, Z | 1 |
| Zhu, N | 1 |
| Goto, MP | 1 |
| Goldman, AS | 1 |
| Ohno, H | 1 |
| Goto, S | 1 |
| Taki, S | 1 |
| Shirasawa, T | 1 |
| Nakano, H | 1 |
| Miyatake, S | 1 |
| Aoe, T | 1 |
| Ishida, Y | 1 |
| Maeda, H | 1 |
| Shirai, T | 1 |
| Strieleman, PJ | 1 |
| Metzger, BE | 1 |
| Ernst, T | 1 |
| Ross, BD | 1 |
| Okuda, Y | 1 |
| Mizutani, M | 1 |
| Tsukahara, K | 1 |
| Yamashita, K | 1 |
| Obosi, LA | 1 |
| Schuette, DG | 1 |
| Europe-Finner, GN | 1 |
| Beadle, DJ | 1 |
| Hen, R | 1 |
| King, LA | 1 |
| Bermudez, I | 1 |
| Liu, L | 1 |
| Moor, RM | 1 |
| Laurie, S | 1 |
| Notarianni, E | 1 |
| Hersey, K | 1 |
| Hu, ZY | 1 |
| Zhang, JP | 1 |
| Sun, GY | 1 |
| Hall, JG | 1 |
| Khandelwal, M | 2 |
| Wu, YK | 3 |
| Borenstein, M | 2 |
| Lauden, A | 1 |
| Kofman, O | 1 |
| Sobolev, Y | 1 |
| Agam, G | 1 |
| Corcoran, J | 1 |
| Colodny, L | 1 |
| Hoffman, RL | 1 |
| Cammarata, PR | 1 |
| Zhou, C | 1 |
| Chen, G | 1 |
| Singh, I | 1 |
| Reeves, RE | 1 |
| Kuszak, JR | 1 |
| Robinson, ML | 1 |
| Shin, JH | 1 |
| Shiota, K | 1 |
| McKiernan, SH | 1 |
| Bavister, BD | 1 |
| Hynes, AC | 1 |
| Sreenan, JM | 1 |
| Kane, MT | 1 |
| Ikonomov, OC | 1 |
| Petrov, T | 1 |
| Soden, K | 1 |
| Shisheva, A | 1 |
| Manji, HK | 1 |
| Rogers, MS | 1 |
| Law, EL | 1 |
| Briton-Jones, CM | 1 |
| Cheung, LP | 1 |
| Haines, CJ | 1 |
| Van Cappellen Van Walsum, AM | 1 |
| Jongsma, HW | 1 |
| Nijhuis, JG | 1 |
| Crevels, J | 1 |
| Engelke, UF | 1 |
| De Abreu, RA | 1 |
| Moolenaar, SH | 1 |
| Oeseburg, B | 1 |
| Burton, LE | 4 |
| Sherman, WR | 1 |
| Packman, PM | 1 |
| Laird, MH | 1 |
| Boshans, RL | 1 |
| van der Horst, CJ | 2 |
| Vogel, F | 1 |
| Ray, RE | 3 |
| Kuo, CH | 1 |
| Iritani, N | 1 |
| Naccarato, WF | 3 |
| Ogasa, K | 1 |
| Kuboyama, M | 1 |
| Kiyosawa, I | 1 |
| Suzuki, T | 1 |
| Itoh, M | 1 |
| Tam, PP | 1 |
| Davis, JS | 1 |
| Bunce, CM | 1 |
| French, PJ | 1 |
| Patton, WN | 1 |
| Turnell, AS | 1 |
| Scott, SA | 1 |
| Michell, RH | 1 |
| Kirk, CJ | 1 |
| Brown, G | 1 |
| Widmer, HR | 1 |
| Knüsel, B | 1 |
| Hefti, F | 1 |
| Guarner, V | 1 |
| Tordet, C | 2 |
| Bourbon, JR | 2 |
| Akashi, M | 1 |
| Akazawa, S | 1 |
| Akazawa, M | 1 |
| Trocino, R | 1 |
| Hashimoto, M | 1 |
| Maeda, Y | 1 |
| Yamamoto, H | 1 |
| Kawasaki, E | 1 |
| Takino, H | 1 |
| Yokota, A | 1 |
| Lakatos, P | 1 |
| Stern, PH | 1 |
| Star, S | 3 |
| Passonneau, JV | 2 |
| Unterman, TG | 3 |
| Freinkel, N | 4 |
| Bry, K | 1 |
| Conrad, KP | 1 |
| Barrera, SA | 1 |
| Friedman, PA | 1 |
| Schmidt, VM | 1 |
| Zeitler, P | 2 |
| Wu, YQ | 1 |
| Handwerger, S | 2 |
| Mirando, MA | 2 |
| Guillette, LJ | 1 |
| Romero, G | 1 |
| Huang, LC | 1 |
| Zhang, CG | 1 |
| Larner, J | 1 |
| Pereira, GR | 1 |
| Baker, L | 1 |
| Egler, J | 1 |
| Corcoran, L | 1 |
| Chiavacci, R | 1 |
| Shafrir, E | 1 |
| Arkinstall, SJ | 1 |
| Jones, CT | 1 |
| Passonneau, J | 1 |
| Ott, TL | 1 |
| Vallet, JL | 1 |
| Davis, M | 1 |
| Bazer, FW | 1 |
| Weigensberg, MJ | 1 |
| Garcia-Palmer, FJ | 1 |
| Sinclair, SH | 1 |
| Nesler, CL | 1 |
| Schwartz, SS | 1 |
| Holub, BJ | 1 |
| Brivet, M | 1 |
| Migayron, F | 1 |
| Roger, J | 1 |
| Cheron, G | 1 |
| Lemonnier, A | 1 |
| Leclerc, J | 1 |
| Miller, ML | 1 |
| Batenburg, JJ | 1 |
| Klazinga, W | 1 |
| van Golde, LM | 1 |
| Ross, TS | 1 |
| Majerus, PW | 1 |
| Snyder, JM | 1 |
| Johnson, RL | 1 |
| Sa Miranda, MC | 1 |
| Aerts, JM | 1 |
| Pinto, RA | 1 |
| Magalhaes, JA | 1 |
| Barranger, JA | 1 |
| Tager, JM | 1 |
| Schram, AW | 1 |
| Anceschi, MM | 1 |
| Petrelli, A | 1 |
| Zaccardo, G | 1 |
| Barbati, A | 1 |
| Cosmi, EV | 1 |
| Sussman, I | 1 |
| Matschinsky, FM | 1 |
| Grummer, RR | 1 |
| Armentano, LE | 1 |
| Marcus, MS | 1 |
| Grove, RI | 1 |
| Willis, WD | 1 |
| Pratt, RM | 1 |
| Nachreiner, RF | 1 |
| Liesman, JS | 1 |
| Egberts, J | 1 |
| Noort, WA | 1 |
| Schrey, MP | 1 |
| Read, AM | 1 |
| Steer, PJ | 1 |
| Doucet, E | 1 |
| Rieutort, M | 1 |
| Pignol, B | 1 |
| Wills, MR | 1 |
| Litjens, JB | 1 |
| Watney, PJ | 1 |
| Rudd, BT | 1 |
| Beutler, E | 1 |
| Kuhl, W | 1 |
| Tyuma, I | 1 |
| Imai, K | 1 |
| Shimizu, K | 1 |
| Bruce, A | 2 |
| Warnes, GM | 1 |
| Amato, F | 1 |
| Seamark, RF | 1 |
| Brenning, R | 1 |
| Svennerholm, L | 1 |
| Shaw, DH | 1 |
| Narumi, K | 1 |
| Tsumita, T | 1 |
| Linari, G | 1 |
| Graf von Spreti, HJ | 1 |
| Everson, GJ | 1 |
| Ely, PA | 1 |
| Gaitonde, MK | 1 |
| Richter, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial[NCT06064669] | 988 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | |||
| Effect of Myoinositol on Serum Asprosin Levels in Pregnant Women[NCT05943158] | 40 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| The Effect Birth Outcome and Diabetes Management of Planned Behavior Theory Based Education Model in Women With Gestational Diabetes[NCT04874922] | 66 participants (Actual) | Interventional | 2021-05-15 | Completed | |||
| Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health - Child Health and Well-being Follow Up Study[NCT05934422] | 510 participants (Anticipated) | Interventional | 2023-06-16 | Enrolling by invitation | |||
| "Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health (NiPPeR)"[NCT02509988] | 1,729 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study[NCT03763669] | 120 participants (Actual) | Interventional | 2018-11-14 | Completed | |||
| Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS:A Double Blind Randomized Placebo Controlled Trial[NCT05653895] | 250 participants (Anticipated) | Interventional | 2022-12-07 | Recruiting | |||
| The Effects of Acetyl L--Carnitine and Myo/Chiro-Inositol on Improving Ovulation, Pregnancy Rate, Ovarian Function and Perceived Stress Response in Patients With PCOS[NCT05767515] | 120 participants (Anticipated) | Interventional | 2023-04-15 | Not yet recruiting | |||
| Altered Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid of Women Undergoing in Vitro Fertilization Has Detrimental Effects on Oocyte and Embryo Quality[NCT03055442] | 34 participants (Actual) | Observational | 2016-10-31 | Completed | |||
| Improved Effects of Myo-inositol in Association With Alpha-lactalbumin in PCOS Women[NCT03422289] | 37 participants (Actual) | Interventional | 2016-11-02 | Completed | |||
| Different Effects of Inositol Stereoisomers on Insulin Sensitivity in Women With Gestational Diabetes[NCT02097069] | 80 participants (Anticipated) | Interventional | 2014-04-30 | Not yet recruiting | |||
| Graceful Lifestyle Changes Intervention Study for Women With PCOS and Infertility[NCT02630485] | 240 participants (Anticipated) | Interventional | 2015-12-31 | Not yet recruiting | |||
| Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial[NCT04273256] | Phase 2/Phase 3 | 226 participants (Anticipated) | Interventional | 2020-02-11 | Recruiting | ||
| Effects of a Supplementation With Zinc and Myo-inositol in Paediatric Obesity[NCT03283813] | Phase 4 | 60 participants (Anticipated) | Interventional | 2018-02-05 | Recruiting | ||
| Reduction of Insulin Therapy Under Myo-inositol for the Treatment of Gestational Diabetes Mellitus: a Randomized Multicenter and Prospective Trial. MYO-GDM Study[NCT03875755] | 1,080 participants (Anticipated) | Interventional | 2020-03-04 | Recruiting | |||
| Evaluation of the Effects of Semen Incubation With ANDROSITOL®DGN on Sperm Motility and Mitochondrial Membrane Potential Before and After Oral Supplementation With Antioxidants and Myo-inositol[NCT04291495] | 25 participants (Actual) | Interventional | 2018-10-23 | Completed | |||
| Myo-inositol May Prevent Gestational Diabetes in Obese Women[NCT01047982] | 220 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| Effect of Myoinositol on Serum Asprosin Levels in PCOS Patients[NCT05951309] | 30 participants (Actual) | Interventional | 2021-09-01 | Completed | |||
| Is the Co-administration of Metformine and CC as Compared to Placebo and CC Superior to Induce Ovulation in PCOS Patients With a Confirmed insulin-resistant-a Double Blind Randomized Clinical Trial[NCT02523898] | Phase 2 | 388 participants (Anticipated) | Interventional | 2015-11-30 | Enrolling by invitation | ||
| [NCT01514942] | Phase 4 | 0 participants | Interventional | Completed | |||
| Improving Oocyte Retrieval Using a Combined Therapy of Recombinant Follicle Stimulating Hormone (rFSH) and Inositol and Melatonin[NCT01267604] | Phase 4 | 0 participants (Actual) | Interventional | 2010-12-31 | Withdrawn | ||
| Effects of Myo-inositol Plus Melatonin in Perimenopausal Women[NCT01325389] | 0 participants | Interventional | Recruiting | ||||
| A Prospective, Randomized, Double Blind, Study on the Clinical Efficacy Myo-inositol Versus D-chiro-inositol in Women Undergoing in Vitro Fertilization Embryo Transfer.[NCT01338844] | Phase 4 | 0 participants | Interventional | Completed | |||
| Improved Maternal and Fetal Outcomes Associated With Inositol Dietary Supplementation in Women With Early Gestational Diabetes Mellitus[NCT01342874] | 30 participants (Actual) | Observational | 2010-08-31 | Completed | |||
| [NCT01511835] | Phase 4 | 0 participants | Interventional | Recruiting | |||
| [NCT01511822] | Phase 4 | 0 participants | Interventional | Completed | |||
| Effects of Inositol Alone or Associated With Alpha-lipoic Acid in Polycystic Ovary Syndrome Treatment[NCT04881851] | 90 participants (Anticipated) | Interventional | 2015-05-07 | Recruiting | |||
| "Influence of Espresso on Adsorption of Orally Administrated Myo-inositol in Humans"[NCT01244399] | 12 participants (Actual) | Observational | 2010-11-30 | Completed | |||
| The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women[NCT01290432] | 15 participants (Actual) | Interventional | 2011-02-28 | Completed | |||
| Evaluation Concerning the Influence of Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment[NCT02385396] | Phase 2 | 217 participants (Actual) | Interventional | Completed | |||
| [NCT01626443] | Phase 4 | 46 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
59 reviews available for inositol and Pregnancy
| Article | Year |
|---|---|
Topics: Diabetes, Gestational; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Inositol | 2023 |
Inositols: From Established Knowledge to Novel Approaches.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Molecular Structure; Polycystic Ovary Syndrome; Pre | 2021 |
Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants.
Topics: Antioxidants; Female; Fertility; Humans; Inositol; Polycystic Ovary Syndrome; Pregnancy; Pregnancy R | 2022 |
Inositols, Probiotics, and Gestational Diabetes: Clinical and Epigenetic Aspects.
Topics: Diabetes, Gestational; Dietary Supplements; Epigenesis, Genetic; Female; Humans; Inositol; Pregnancy | 2022 |
Myo-inositol supplementation for the prevention of gestational diabetes: A meta-analysis of randomized controlled trials.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Infant, Newborn; Inositol; Pregnancy; Ra | 2022 |
Effectiveness of five interventions used for prevention of gestational diabetes: A network meta-analysis.
Topics: Diabetes, Gestational; Exercise; Female; Humans; Inositol; Network Meta-Analysis; Pregnancy; Probiot | 2022 |
The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Glucose; Humans; Incidence; Infant, Newborn; Ino | 2022 |
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; Infant, Newborn; Inositol | 2022 |
Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome.
Topics: Dysbiosis; Female; Humans; Inositol; Insulin Resistance; Lactalbumin; Polycystic Ovary Syndrome; Pre | 2022 |
Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.
Topics: Female; Humans; Hypoglycemic Agents; Inositol; Live Birth; Metformin; Polycystic Ovary Syndrome; Pre | 2022 |
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypert | 2023 |
Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Diabetes, Gestational; Female; Humans; Hypertension, Pregnancy-Induced; Hypoglycemia; Infant, Newbor | 2023 |
The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypertension, Pregnancy-Induced; Infant, | 2023 |
Non-pharmacological management of gestational diabetes: The role of myo-inositol.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Fetal Development; Humans; Inositol; Pregnancy | 2019 |
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Risk Factors | 2019 |
Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
Topics: Animals; Biomarkers; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypo | 2019 |
Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.
Topics: Diabetes, Gestational; Diet, Diabetic; Dietary Supplements; Exercise; Fatty Acids, Omega-3; Female; | 2020 |
An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs).
Topics: Animals; Diabetes, Gestational; Female; Humans; Infant, Newborn; Inositol; Insulin; Neural Tube Defe | 2020 |
A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin; Placenta; Polycystic Ovary Syndrome; Pregn | 2022 |
Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies.
Topics: Female; Fertilization in Vitro; Humans; Inositol; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Ra | 2021 |
Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk.
Topics: COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Inositol; Pregnancy; Pregnancy | 2021 |
Dietary supplementation for gestational diabetes prevention and management: a meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Randomized C | 2021 |
Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth.
Topics: Animals; Female; Fertilization; Humans; Inositol; Melatonin; Oocytes; Parturition; Pregnancy; Pregna | 2021 |
Effect of inositol and its derivatives on diabetes: a systematic review.
Topics: Animals; Blood Glucose; Databases, Factual; Diabetes Mellitus, Type 2; Diabetes, Gestational; Fastin | 2019 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Fe | 2017 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Fe | 2017 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Fe | 2017 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Fe | 2017 |
Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET.
Topics: Adult; Dietary Supplements; Embryo Transfer; Female; Fertilization in Vitro; Humans; Infertility, Fe | 2017 |
The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin Resistance; Polycystic Ovary Syndrome; Preg | 2018 |
Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Pregnancy; Randomized Controlled Trials as Topic; V | 2018 |
The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes, Gestational; Female; Gestational Age; Humans; Inositol; Pregnancy; Premature Birth; | 2019 |
Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Topics: Disease Management; Female; Fertilization in Vitro; Folic Acid; Glucose; Humans; Infertility, Female | 2018 |
Effects of inositol on glucose homeostasis: Systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Inositol; Insulin Resi | 2019 |
Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Infant, Newborn; Inositol; Insulin; Odd | 2019 |
Inositol for subfertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Birth Rate; Clomiphene; Combined Modality Therapy; Fema | 2018 |
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Humans; In | 2019 |
Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2019 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Topics: Animals; Blood Glucose; Cataract; Diabetes, Gestational; Diabetic Nephropathies; Diet; Female; Human | 2013 |
Myoinositol: a new marker of intrauterine growth restriction?
Topics: Biomarkers; Female; Fetal Growth Retardation; Humans; Inositol; Pregnancy | 2013 |
Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies.
Topics: Clinical Trials as Topic; Databases, Factual; Diabetes, Gestational; Female; Humans; Inositol; Nutri | 2015 |
Prevention of gestational diabetes mellitus: Where are we now?
Topics: Diabetes, Gestational; Diet; Dietary Supplements; Exercise Therapy; Female; Humans; Hypoglycemic Age | 2015 |
Preventive and Therapeutic Role of Dietary Inositol Supplementation in Periconceptional Period and During Pregnancy: A Summary of Evidences and Future Applications.
Topics: Animals; Dietary Supplements; Female; Folic Acid; Humans; Inositol; Neural Tube Defects; Preconcepti | 2016 |
New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.
Topics: Animals; Arachidonic Acid; Congenital Abnormalities; Female; Glucose; Humans; Hypoxia-Inducible Fact | 2016 |
Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Vitamin B Complex | 2015 |
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.
Topics: Diabetes, Gestational; Female; Humans; Incidence; Inositol; Isomerism; Pregnancy; Prenatal Care; Ran | 2015 |
Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.
Topics: Animals; Diabetes, Gestational; Dietary Supplements; Female; Humans; Incidence; Inositol; Insulin Re | 2016 |
Inositol, neural tube closure and the prevention of neural tube defects.
Topics: Animals; Clinical Trials as Topic; Dietary Supplements; Disease Models, Animal; Female; Folic Acid; | 2017 |
Ovulation induction in polycystic ovary syndrome: Current options.
Topics: Anovulation; Anti-Obesity Agents; Aromatase Inhibitors; Bariatric Surgery; Clomiphene; Diet Therapy; | 2016 |
Can we prevent diabetic birth defects with micronutrients?
Topics: Animals; Antioxidants; Arachidonic Acid; Congenital Abnormalities; Dietary Supplements; Female; Feta | 2009 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Live Bir | 2010 |
Contribution of myo-inositol and melatonin to human reproduction.
Topics: Diet; Dietary Supplements; Embryonic Development; Female; Humans; Inositol; Inositol Phosphates; Mal | 2011 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Female; Inositol; Insulin | 2012 |
Congenital malformations in offspring of diabetic mothers--animal and human studies.
Topics: Animals; Arachidonic Acid; Congenital Abnormalities; Diabetes Complications; Female; Gene Expression | 2003 |
Artificial fetal lung maturation--prevention of antenatal complications in premature deliveries.
Topics: Adrenergic beta-Agonists; Aminophylline; Bronchodilator Agents; Drug Administration Schedule; Female | 2005 |
Diabetic embryopathy.
Topics: Animals; Congenital Abnormalities; Female; Fetal Diseases; Humans; Inositol; Pregnancy; Pregnancy in | 1994 |
The pathogenesis of diabetes-associated congenital malformations.
Topics: Animals; Antioxidants; Arachidonic Acids; Congenital Abnormalities; Embryonic and Fetal Development; | 1996 |
Advances in the understanding of diabetic embryopathy: signal transduction.
Topics: Animals; Arachidonic Acid; Congenital Abnormalities; Diabetes Mellitus, Experimental; Embryo, Mammal | 1996 |
What are the molecular mechanisms of neural tube defects?
Topics: Animals; Disease Models, Animal; Drug Resistance; Female; Folic Acid; Humans; Inositol; Mice; Mice, | 1998 |
Prevention of neural tube defects: vitamins, enzymes and genes.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Cystathionine beta-Synthase; Fem | 1998 |
Inositol--clinical applications for exogenous use.
Topics: Animals; Female; Humans; Inositol; Pregnancy | 1998 |
Metabolism and function of myo-inositol and inositol phospholipids.
Topics: Absorption; Animals; Arachidonic Acid; Arachidonic Acids; Biological Transport, Active; Carrier Prot | 1986 |
49 trials available for inositol and Pregnancy
| Article | Year |
|---|---|
Myoinositol
Topics: Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Inositol; Metformin; Ovarian | 2022 |
Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Humans; Incidence; In | 2022 |
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
Topics: Diabetes, Gestational; Double-Blind Method; Female; Humans; Inositol; Insulin Resistance; Male; Pilo | 2022 |
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Folic Acid; Humans; Inositol; Insulin Resistance | 2023 |
Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics, and micronutrient supplement: secondary outcomes of the NiPPeR randomized trial.
Topics: Dietary Supplements; Double-Blind Method; Female; Humans; Inositol; Micronutrients; Obesity; Overwei | 2023 |
A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
Topics: Female; Humans; Hypoglycemic Agents; Inositol; Insulin; Insulin Resistance; Metformin; Polycystic Ov | 2023 |
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.
Topics: Adult; Dietary Supplements; Drug Combinations; Embryo Implantation; Female; Folic Acid; Follicle Sti | 2020 |
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Glucose Tolerance Test; Glycated Hemoglobin; Gre | 2020 |
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial.
Topics: Adult; Cholecalciferol; Dose-Response Relationship, Drug; Female; Fertilization in Vitro; Humans; In | 2020 |
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Folic Acid; Humans; Infant; Inositol; Pregnancy; | 2022 |
Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Infertility, Female; Inositol | 2021 |
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Topics: Diabetes, Gestational; Dietary Supplements; Electric Impedance; Female; Folic Acid; Humans; Infant, | 2021 |
Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial.
Topics: Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; India; Inositol; Insulin; Metformin; Pil | 2021 |
Topics: Dietary Supplements; Double-Blind Method; Female; Humans; Infant, Newborn; Inositol; Micronutrients; | 2021 |
Topics: Dietary Supplements; Double-Blind Method; Female; Humans; Infant, Newborn; Inositol; Micronutrients; | 2021 |
Topics: Dietary Supplements; Double-Blind Method; Female; Humans; Infant, Newborn; Inositol; Micronutrients; | 2021 |
Topics: Dietary Supplements; Double-Blind Method; Female; Humans; Infant, Newborn; Inositol; Micronutrients; | 2021 |
The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial.
Topics: Adult; Double-Blind Method; Female; Fertilization; Folic Acid; Humans; Infertility, Female; Inositol | 2021 |
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study.
Topics: Adult; Birth Weight; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; Female; Folic | 2021 |
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Beverages; Biomarkers; Blood Glucose; Clinical Protocols; D | 2017 |
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Beverages; Biomarkers; Blood Glucose; Clinical Protocols; D | 2017 |
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Beverages; Biomarkers; Blood Glucose; Clinical Protocols; D | 2017 |
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Beverages; Biomarkers; Blood Glucose; Clinical Protocols; D | 2017 |
The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
Topics: Administration, Oral; Adolescent; Adult; Diabetes, Gestational; Dietary Supplements; Female; Glucose | 2017 |
Could myo-inositol soft gel capsules outperform clomiphene in inducing ovulation? Results of a pilot study.
Topics: Adolescent; Adult; Capsules; Clomiphene; Drug Therapy, Combination; Female; Fertility Agents, Female | 2017 |
Physiological Intra-Cytoplasmic Sperm Injection (PICSI) outcomes after oral pretreatment and semen incubation with myo-inositol in oligoasthenoteratozoospermic men: results from a prospective, randomized controlled trial.
Topics: Administration, Oral; Adult; Embryo Transfer; Female; Folic Acid; Humans; Infertility; Inositol; Mal | 2017 |
Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality?
Topics: Adult; Blastocyst; Embryo Transfer; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inosit | 2017 |
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women.
Topics: Adult; Dietary Supplements; Drug Combinations; Drug Resistance; Female; Folic Acid; Humans; Inositol | 2018 |
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
Topics: Adolescent; Adult; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Humans; Inositol | 2018 |
A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol.
Topics: Administration, Oral; Adolescent; Adult; Diet, Healthy; Exercise; Female; Fertility Agents, Female; | 2018 |
Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial.
Topics: Adult; Birth Rate; Drug Synergism; Drug Therapy, Combination; Female; Fertility Agents, Female; Fert | 2019 |
The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole.
Topics: Adult; Female; Folic Acid; Humans; Infertility, Female; Inositol; Letrozole; Metformin; Ovulation In | 2019 |
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Topics: Adolescent; Adult; Birth Rate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Compoundi | 2019 |
The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
Topics: Adult; Biomarkers; Drug Therapy, Combination; Female; Fertilization in Vitro; Humans; Inositol; Oocy | 2013 |
Inositol: effects on oocyte quality in patients undergoing ICSI. An open study.
Topics: Female; Folic Acid; Humans; Inositol; Male; Oocytes; Pregnancy; Sperm Injections, Intracytoplasmic | 2013 |
Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Femal | 2014 |
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
Topics: Adult; Clomiphene; Female; Fertility Agents, Female; Humans; Infant, Newborn; Infertility, Female; I | 2015 |
Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: a prospective, bicentric, randomized trial on sibling oocytes.
Topics: Adult; Embryo Transfer; Female; Fertilization; Fertilization in Vitro; Humans; Infertility, Male; In | 2015 |
Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Gonadotropins; Humans; Inositol; Oocytes; Ovulati | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Comorbidity; Diabetes, Gestational; Dietary Supplements; Drug | 2015 |
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
Topics: Adult; Antioxidants; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Embryo Tra | 2016 |
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes, Gestational; Dietary Supplements; Female; Humans; I | 2016 |
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial.
Topics: Adult; Cohort Studies; Dietary Supplements; Double-Blind Method; Feasibility Studies; Female; Folic | 2016 |
Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial.
Topics: Adult; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Inositol; Inseminatio | 2017 |
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
Topics: Adult; Anovulation; Dietary Supplements; Drug Therapy, Combination; Female; Fertility Agents, Female | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Inositol; Melatonin; Oocytes; Pregnancy; | 2010 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.
Topics: Adiponectin; Adult; Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glucose Toler | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Topics: Adult; Cohort Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; | 2011 |
Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes.
Topics: Adult; Carbon Isotopes; Cesarean Section; Female; Humans; Hydrogen; Infant, Newborn; Inositol; Isoto | 2012 |
Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
Topics: Adult; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; Double-Blind Method; Female | 2013 |
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy; Prospective S | 2013 |
Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy.
Topics: Aspartic Acid; Brain; Brain Chemistry; Choline; Embryonic and Fetal Development; Female; Gestational | 2002 |
Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
Topics: Adult; Drug Therapy, Combination; Female; Folic Acid; Humans; Infertility, Female; Inositol; Live Bi | 2007 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Humans; Inositol; Male; Oocytes; Polycystic Ovary | 2009 |
[Enantaldehydes and furaldehydes in molimina crurum nocturna including "restless legs". A comparative trial with carbacholine, inositolnicotinate, and placebo].
Topics: Aged; Aldehydes; Carbachol; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Female; Furalde | 1969 |
195 other studies available for inositol and Pregnancy
| Article | Year |
|---|---|
Myo-Inositol Supplementation in Suckling Rats Protects against Adverse Programming Outcomes on Hypothalamic Structure Caused by Mild Gestational Calorie Restriction, Partially Comparable to Leptin Effects.
Topics: Animals; Animals, Suckling; Caloric Restriction; Dietary Supplements; Female; Hypothalamus; Inositol | 2021 |
Differential placental CpG methylation is associated with chronic lung disease of prematurity.
Topics: CpG Islands; DNA Methylation; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, | 2022 |
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes.
Topics: Diabetes, Gestational; Female; Humans; Inositol; Insulin; Insulin Resistance; Polycystic Ovary Syndr | 2022 |
Advances in non-hormonal pharmacotherapy for the treatment of male infertility: the role of inositols.
Topics: Female; Humans; Infertility, Male; Inositol; Male; Pregnancy; Semen; Sperm Motility | 2022 |
A Neurometabolic Pattern of Elevated Myo-Inositol in Children Who Are HIV-Exposed and Uninfected: A South African Birth Cohort Study.
Topics: Birth Cohort; Child; Child, Preschool; Cohort Studies; Creatine; Female; HIV Infections; Humans; Ino | 2022 |
Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes.
Topics: Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glycemic Control; Humans; Infant, | 2022 |
Myo-Inositol Moderates Glucose-Induced Effects on Human Placental
Topics: Arachidonic Acid; Diabetes, Gestational; Ethanolamines; Female; Glucose; Humans; Inositol; Phospholi | 2022 |
Genetic Effects of ITPK1 Polymorphisms on the Risk of Neural Tube Defects: a Population-Based Study.
Topics: Case-Control Studies; Female; Genotype; Humans; Inositol; Neural Tube Defects; Polymorphism, Single | 2023 |
Hormonal profile in women with infertility against the background of polycystic ovary syndrome depending on the type of pre-pregnancy pre-treatment.
Topics: Cholecalciferol; Female; Humans; Infertility, Female; Inositol; Ovulation Induction; Polycystic Ovar | 2022 |
A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System.
Topics: Cost-Benefit Analysis; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Inosito | 2023 |
An enzymatic assay for quantification of inositol in human term placental tissue.
Topics: Enzyme Assays; Female; Humans; Inositol; Placenta; Pregnancy; Sugar Alcohol Dehydrogenases | 2019 |
The effects of myo-inositol and probiotic supplementation in a high-fat-fed preclinical model of glucose intolerance in pregnancy.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes, Gestational; Diet, High-Fat; Dietary Supplements; | 2020 |
The Effects of Inositol Metabolism in Pregnant Women on Offspring in the North and South of China.
Topics: Adult; China; Congenital Abnormalities; Female; Fetal Development; Geography; Humans; Incidence; Inf | 2020 |
Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
Topics: Adult; Drug Therapy, Combination; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotr | 2020 |
Maternal Supplementation of Inositols, Fucoxanthin, and Hydroxytyrosol in Pregnant Murine Models of Hypertension.
Topics: Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Dr | 2020 |
Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus.
Topics: Blood Glucose; Diabetes, Gestational; Female; Humans; Inositol; Inositol Oxygenase; Insulin; Insulin | 2022 |
Myo-inositol impact on sperm motility in vagina and evaluation of its effects on foetal development.
Topics: Adult; Female; Fetal Development; Humans; Infertility; Inositol; Italy; Male; Pregnancy; Pregnancy R | 2020 |
Use of a Combination of Insulin Sensitizers and Antioxidant Supplements in the Management of Pregnancy Hypertensive Disorders.
Topics: Animals; Antioxidants; Dietary Supplements; Female; Humans; Hypertension, Pregnancy-Induced; Inosito | 2020 |
High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort.
Topics: Adiposity; Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Female; Humans; Infant, Newbor | 2021 |
Plasma and urinary inositol isomer profiles measured by UHPLC-MS/MS reveal differences in scyllo-inositol levels between non-pregnant and pregnant women.
Topics: Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Inositol; Limit of Detec | 2020 |
Diet Alters Micronutrient Pathways in the Gut and Placenta that Regulate Fetal Growth and Development in Pregnant Mice.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Caloric Restriction; Diet; Diet, H | 2021 |
Maternal Inositol Status and Neural Tube Defects: A Role for the Human Yolk Sac in Embryonic Inositol Delivery?
Topics: Female; Folic Acid; Humans; Inositol; Neural Tube Defects; Pregnancy; Spinal Dysraphism; Yolk Sac | 2021 |
Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.
Topics: Adult; Blood Glucose; Case-Control Studies; Cells, Cultured; Diabetes, Gestational; Down-Regulation; | 2021 |
Neural tube defects: role of lithium carbonate exposure in embryonic neural development in a murine model.
Topics: 5'-Nucleotidase; Animals; Central Nervous System; Disease Models, Animal; Female; Glycogen Synthase | 2021 |
Effects of α-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Dietary Supplements; DNA, Mitochondrial; Female; Fert | 2020 |
Sex-Specific Effects of Myo-Inositol Ingested During Lactation in the Improvement of Metabolic Health in Adult Rats.
Topics: Adipose Tissue, White; Animals; Body Weight; Caloric Restriction; Dietary Supplements; Eating; Energ | 2021 |
Effectiveness and acceptability of myoinositol in prevention of gestational diabetes mellitus: A protocol for systematic review and meta-analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Meta-Analysis as Topic; Pregna | 2021 |
Myoinositol Reduces Inflammation and Oxidative Stress in Human Endothelial Cells Exposed In Vivo to Chronic Hyperglycemia.
Topics: Adult; Antioxidants; Cell Adhesion; Cell Adhesion Molecules; Diabetes, Gestational; Female; Human Um | 2021 |
[The myo-inositol is beneficial in the therapy of pregnancy with insulin-dependent type 2 diabetes and polycystic ovary syndrome].
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Infant, Newborn; Inositol; Polycystic Ovary Syndro | 2017 |
A comparative study between myo-inositol and metformin in the treatment of insulin-resistant women.
Topics: Adult; Body Mass Index; Fasting; Female; Folic Acid; Humans; Inositol; Insulin; Insulin Resistance; | 2017 |
Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2017 |
Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results.
Topics: Adult; Diabetes, Gestational; Dietary Supplements; Female; Glucose Tolerance Test; Glycated Hemoglob | 2017 |
Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Nutrition Therapy; Pregn | 2017 |
Response to Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Nutrition Therapy; Pregn | 2017 |
Cerebral Osmolytes and Plasma Osmolality in Pregnancy and Preeclampsia: A Proton Magnetic Resonance Spectroscopy Study.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Cerebrovascular Circulation; Choline; Creatine; | 2018 |
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Fetal Growth R | 2018 |
Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model.
Topics: Animals; Body Weight; Disease Models, Animal; Female; Granulosa Cells; Inositol; Light; Male; Mice, | 2019 |
Effects of myo-inositol on glucose variability in women with gestational diabetes.
Topics: Adult; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes, Gestational; Dietary Supplements; | 2018 |
Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study.
Topics: Adult; Female; Folic Acid; Humans; Infertility, Male; Inositol; Male; Middle Aged; Pregnancy; Reacti | 2018 |
Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols.
Topics: Animals; Biomarkers; Drug Administration Schedule; Female; Hypertension; Inositol; Male; Metabolic S | 2019 |
Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome.
Topics: Acetylcysteine; Complementary Therapies; Dietary Supplements; Female; Humans; Infertility; Inositol; | 2019 |
Effect of alpha-lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women.
Topics: Abortion, Habitual; Biopsy; Caspase 1; Cells, Cultured; Down-Regulation; Endometrium; Enzyme-Linked | 2019 |
Can a dietary supplement prevent gestational diabetes mellitus?
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Inositol; Pregnancy | 2013 |
Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation.
Topics: 3-Hydroxybutyric Acid; Adult; Aminoisobutyric Acids; Betaine; Creatine; Cytomegalovirus; Cytomegalov | 2013 |
Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study.
Topics: Astrocytes; Brain; Case-Control Studies; Creatine; Female; Fetal Growth Retardation; Fetus; Humans; | 2013 |
Low and high dietary protein:carbohydrate ratios during pregnancy affect materno-fetal glucose metabolism in pigs.
Topics: Adaptation, Physiological; Animals; Area Under Curve; Blood Glucose; Brain; Diet; Diet, Carbohydrate | 2014 |
The maternal ITPK1 gene polymorphism is associated with neural tube defects in a high-risk Chinese population.
Topics: Adult; Asian People; Case-Control Studies; China; Female; Genotype; Humans; Inositol; Inositol Phosp | 2014 |
[Statement of the Polish Gynecological Society on the application of myo-inozytol in patients with PCOS (polycystic ovary syndrome)].
Topics: Congresses as Topic; Female; Gynecology; Humans; Inositol; Inservice Training; Obstetrics; Ovulation | 2014 |
Myo-inositol in Down syndrome amniotic fluid. A case-control study.
Topics: Adult; Amniotic Fluid; Biomarkers; Case-Control Studies; Down Syndrome; Female; Humans; Inositol; Pr | 2014 |
[Role of D-chiro-inositol in glucidic metabolism alterations during pregnancy].
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Hunger; Hypoglycemia; Hypoglycemic Agen | 2014 |
Increased trophoblast expression of NFAT5/TonEBP in pre-eclamptic placentas and hyperosmolar-treated BeWo cells.
Topics: Aldehyde Reductase; Case-Control Studies; Cells, Cultured; Choriocarcinoma; Extracellular Signal-Reg | 2014 |
Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus.
Topics: Adult; Biomarkers; Case-Control Studies; Diabetes, Gestational; Female; Gas Chromatography-Mass Spec | 2016 |
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension.
Topics: Adult; Amniotic Fluid; Case-Control Studies; Diabetes, Gestational; Female; Humans; Hypertension, Pr | 2016 |
Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.
Topics: Animals; Aspartic Acid; Behavior, Animal; Creatine; Diet, High-Fat; Dietary Supplements; Fatty Acids | 2015 |
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.
Topics: Congenital Abnormalities; Diabetes, Gestational; Female; Humans; Inositol; Insulin Resistance; Metab | 2015 |
The effect of FT500 Plus(®) on ovarian stimulation in PCOS women.
Topics: Adult; Antioxidants; Dietary Supplements; Female; Fertility Agents, Female; Folic Acid; Follicular F | 2016 |
A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin.
Topics: Adult; Blood Glucose Self-Monitoring; Combined Modality Therapy; Diabetes, Gestational; Diet; Female | 2016 |
The Potential Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus.
Topics: Animals; Diabetes, Gestational; Dietary Supplements; Female; Humans; Inositol; Pregnancy; Randomized | 2016 |
The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity.
Topics: Animals; Biomarkers; Blood Glucose; Dietary Supplements; Disease Models, Animal; Female; Gastric Inh | 2016 |
Quantification of plasma myo-inositol using gas chromatography-mass spectrometry.
Topics: Anencephaly; Female; Gas Chromatography-Mass Spectrometry; Humans; Inositol; Male; Mass Screening; N | 2016 |
Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate.
Topics: Animals; Aspartic Acid; Brain; Choline; Creatine; Echoencephalography; Female; Fetus; Glutamic Acid; | 2016 |
The Effects of Myo-Inositol and B and D Vitamin Supplementation in the db/+ Mouse Model of Gestational Diabetes Mellitus.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Dietary Supplements | 2017 |
Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Linolenic Acid; Animals; Animals, | 2009 |
Determination of the NFAT5/TonEBP transcription factor in the human and ovine placenta.
Topics: Animals; Female; Humans; Inositol; Osmolar Concentration; Placenta; Pregnancy; RNA, Messenger; Sheep | 2009 |
The tissue and plasma concentration of polyols and sugars in sheep intrauterine growth retardation.
Topics: Animals; Carbohydrate Metabolism; Carbohydrates; Female; Fetal Growth Retardation; Fetus; Fructose; | 2010 |
The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Topics: Adult; Case-Control Studies; Chi-Square Distribution; Dietary Supplements; Female; Fertility Agents, | 2011 |
Inositol effects on ovulation induction in patients with polycystic ovary syndrome.
Topics: Dietary Supplements; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; I | 2011 |
Comments on the role of inositol supplementation in patients with polycystic ovary syndrome.
Topics: Dietary Supplements; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; I | 2011 |
The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Topics: Dietary Supplements; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; I | 2011 |
Establishment of an advanced chemically defined medium for early embryos derived from in vitro matured and fertilized bovine oocytes.
Topics: Animals; Blastocyst; Cattle; Culture Media, Serum-Free; Embryo Transfer; Embryonic Development; Fema | 2011 |
Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy.
Topics: Adult; Cohort Studies; Dietary Supplements; Female; Folic Acid; Heterozygote; Humans; Infant, Newbor | 2011 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Myo-inositol may prevent gestational diabetes in PCOS women.
Topics: Adult; Diabetes, Gestational; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Polycystic O | 2012 |
Placental TonEBP/NFAT5 osmolyte regulation in an ovine model of intrauterine growth restriction.
Topics: Aldehyde Reductase; Animals; Female; Fetal Growth Retardation; Inositol; Models, Animal; NADP; NFATC | 2012 |
Effects of alcohol, lithium, and homocysteine on nonmuscle myosin-II in the mouse placenta and human trophoblasts.
Topics: Animals; Cell Line; Cell Movement; Central Nervous System Depressants; Endothelial Cells; Ethanol; F | 2012 |
MR spectroscopy of the fetal brain: is it possible without sedation?
Topics: Aspartic Acid; Brain; Choline; Conscious Sedation; Creatine; Female; Fetal Diseases; Fetal Growth Re | 2013 |
Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.
Topics: Adult; Female; Fertilization in Vitro; Folic Acid; Humans; Infertility, Female; Inositol; Pilot Proj | 2012 |
D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects.
Topics: Administration, Oral; Animals; Drug Resistance; Embryonic and Fetal Development; Female; Folic Acid; | 2002 |
Maturation of the human fetal brain as observed by 1H MR spectroscopy.
Topics: Aspartic Acid; Brain; Choline; Creatine; Dipeptides; Female; Fetus; Gestational Age; Humans; Inosito | 2002 |
Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls?
Topics: Adult; Amniotic Fluid; Female; Gestational Age; Glucose; Humans; Inositol; Maternal Age; Pregnancy; | 2003 |
Antenatal proton MR spectroscopy of the human brain in vivo.
Topics: Aspartic Acid; Brain; Choline; Creatine; Female; Fetus; Gestational Age; Humans; Inositol; Magnetic | 2003 |
Reversible posterior leukoencephalopathy in eclampsia.
Topics: Adult; Aspartic Acid; Cerebral Arterial Diseases; Choline; Creatine; Female; Humans; Inositol; Magne | 2003 |
[Treatment of hyperemesis gravidarum with combined inositol and pyridoxine].
Topics: Female; Humans; Hyperemesis Gravidarum; Inositol; Pregnancy; Pregnancy Complications; Pyridoxine; Vi | 1955 |
[Inositol in vomiting in pregnancy].
Topics: Female; Humans; Inositol; Pregnancy; Pregnancy Complications; Vomiting | 1956 |
[Use of cardiotrophotherapy in pregnancy].
Topics: Cytochromes; Female; Heart Diseases; Humans; Inositol; Pregnancy; Vitamin A; Vitamin K; Vitamins | 1958 |
Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3.
Topics: Animals; DNA-Binding Proteins; Drug Resistance; Epithelium; Female; Folic Acid; Humans; Inositol; Mi | 2003 |
Phenotype of the neural tube defect mouse model bent tail is not sensitive to maternal folinic acid, myo-inositol, or zinc supplementation.
Topics: Animals; Diet; Disease Models, Animal; DNA; Embryo Loss; Female; Genotype; Inositol; Leucovorin; Lit | 2003 |
Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study.
Topics: Adult; Blood Glucose; Case-Control Studies; Cleft Lip; Cleft Palate; Dietary Supplements; Erythrocyt | 2004 |
Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment.
Topics: Embryo, Mammalian; Female; Fetus; Fructose; Galactose; Gestational Age; Glucose; Glycerol; Humans; I | 2005 |
Periconceptional dietary intake of myo-inositol and neural tube defects in offspring.
Topics: Female; Humans; Inositol; Maternal Exposure; Neural Tube Defects; Pregnancy; Prenatal Exposure Delay | 2005 |
Myo-inositol, glucose and zinc concentrations determined in the preconceptional period, during and after pregnancy.
Topics: Adult; Blood Glucose; Erythrocytes; Female; Humans; Hypertension; Inositol; Linear Models; Longitudi | 2006 |
Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term.
Topics: Arteries; Carbohydrates; Chromatography, High Pressure Liquid; Erythritol; Female; Gestational Age; | 2005 |
Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anticonvulsants; Drug Synergism; Embryo | 2006 |
Effect of prolactin on inositol uptake in mouse mammary gland explants.
Topics: Animals; Female; Hydrocortisone; Inositol; Insulin; Mammary Glands, Animal; Mice; Pregnancy; Prolact | 2007 |
Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Cystathionine beta-Synthase; Drug Resistanc | 2008 |
Comments on inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
Topics: Drug Resistance; Female; Folic Acid; Humans; Infant, Newborn; Inositol; Neural Tube Defects; Pregnan | 2008 |
Galactose toxicity and myoinositol metabolism in the developing rat brain.
Topics: Alcohols; Amniotic Fluid; Animals; Animals, Newborn; Brain; Brain Chemistry; Carbon Isotopes; Dietar | 1967 |
Carbohydrate metabolism in the sheep placenta.
Topics: Alcohols; Animals; Carbohydrate Metabolism; Carbon Isotopes; Female; Fructose; Glucose; Glycerol; In | 1967 |
Inositol as a lipotropic agent in dairy cattle diets.
Topics: Animals; Cattle; Cattle Diseases; Fatty Liver; Female; Food, Fortified; Inositol; Insulin; Liver; Pr | 1984 |
Stable isotope dilution analysis of galactitol in amniotic fluid: an accurate approach to the prenatal diagnosis of galactosemia.
Topics: Amniotic Fluid; Female; Galactitol; Galactosemias; Gas Chromatography-Mass Spectrometry; Humans; Ino | 1984 |
Effect of myo-inositol on the glycerophospholipid composition of adult and fetal rat lung tissue.
Topics: Animals; Female; Fetus; Inositol; Lung; Maternal-Fetal Exchange; Phosphatidylglycerols; Phosphatidyl | 1984 |
myo-Inositol homeostasis in the human fetus.
Topics: Female; Fetal Blood; Fetus; Homeostasis; Humans; Inositol; Myo-Inositol-1-Phosphate Synthase; Phosph | 1983 |
Characterization of a new oligosaccharide containing myo-inositol found in pregnancy urine.
Topics: Chromatography, Gel; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Mass Spectrometry; O | 1983 |
Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure.
Topics: Adult; Amniotic Fluid; Female; Humans; Infant, Newborn; Inositol; Pregnancy; Pulmonary Alveolar Prot | 1982 |
Effects of maternal insulin or glucose infusion on the fetus: study on lung surfactant phospholipids, plasma myoinositol, and fetal growth in the rabbit.
Topics: Animals; Blood Glucose; Female; Fetal Growth Retardation; Fetal Organ Maturity; Fetus; Glucose; Infu | 1982 |
Estimation of free myo-inositol in milks of various species and its source in milk of rats (Rattus norvegicus).
Topics: Animals; Diet; Female; Glucose; Inositol; Lactation; Mammals; Milk; Pregnancy; Rats; Species Specifi | 1982 |
Regulation of lamellar body acidic glycerophospholipid biosynthesis in fetal rabbit lung in organ culture.
Topics: Animals; Female; Fetus; Glycerol; Hydrocortisone; Inositol; Lung; Organ Culture Techniques; Phosphat | 1982 |
myo-inositol in the reproductive tract of the female rat.
Topics: Animals; Biological Transport, Active; Estrus; Female; Genitalia, Female; Inositol; Pregnancy; Rats; | 1982 |
Effects of vitamin A and inositol on term weights of H-2 congenic mice.
Topics: Animals; Birth Weight; Body Weight; Diet; Embryonic and Fetal Development; Female; Inositol; Mice; M | 1995 |
Prenatal ethanol exposure reduces phosphoinositide hydrolysis stimulated by quisqualate in rat cerebellar granule cell cultures.
Topics: Animals; Cells, Cultured; Cerebellum; Ethanol; Excitatory Amino Acid Agonists; Excitatory Amino Acid | 1994 |
Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand.
Topics: Animals; Base Sequence; CD3 Complex; Cell Line; DNA Primers; DNA-Binding Proteins; Female; Genes, Le | 1994 |
Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis?
Topics: Animals; Congenital Abnormalities; Embryo, Mammalian; Embryonic and Fetal Development; Female; Gesta | 1993 |
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.
Topics: Brain; Brain Chemistry; Child; Child, Preschool; Choline; Creatine; Female; Gestational Age; Humans; | 1993 |
Murine fetal development enhanced by dietary vitamin A, corn oil, and inositol.
Topics: Animals; Corn Oil; Diet; Embryonic and Fetal Development; Extremities; Eye; Female; Gestational Age; | 1993 |
Eicosapentaenoic acid prevents the inhibition of myo-inositol uptake induced by high glucose concentration in cultured human endothelial cells.
Topics: Cells, Cultured; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Glucose; Humans; Inositol; Pr | 1993 |
Functional characterisation of the Drosophila 5-HTdro1 and 5-HTdro2B serotonin receptors in insect cells: activation of a G(alpha) s-like protein by 5-HTdro1 but lack of coupling to inhibitory G-proteins by 5-HTdro2B.
Topics: Animals; Baculoviridae; Brain; Cell Line; Cyclic AMP; Drosophila; Drosophila Proteins; Female; GTP-B | 1996 |
Nuclear remodelling and early development in cryopreserved, porcine primordial germ cells following nuclear transfer into in vitro-matured oocytes.
Topics: Animals; Blastomeres; Cell Cycle; Cell Nucleus; Cryopreservation; Embryonic and Fetal Development; F | 1995 |
In utero hypoxic ischemia decreases the cholinergic agonist-stimulated poly-phosphoinositide turnover in the developing rat brain.
Topics: Animals; Brain; Carbachol; Constriction; Female; Hypoxia; Inositol; Ischemia; Lithium Chloride; Para | 1995 |
Give the embryo a chance.
Topics: Animals; Drug Administration Schedule; Embryo, Mammalian; Female; Fertilization; Folic Acid; Hematin | 1997 |
Inositol prevents folate-resistant neural tube defects in the mouse.
Topics: Animals; Arachidonic Acid; Embryo, Mammalian; Female; Folic Acid; Gene Expression Regulation, Develo | 1997 |
Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Embryonic and Fetal Development; Female; Hyperglycemia; In | 1997 |
Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant.
Topics: Animals; Antioxidants; Blood Glucose; Congenital Abnormalities; Diabetes Mellitus, Experimental; Dru | 1997 |
Oral maternal inositol supplementation does not increase rat conceptus inositol levels.
Topics: Administration, Oral; Animals; Body Weight; Female; Humans; Inositol; Maternal-Fetal Exchange; Pregn | 1997 |
Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
Topics: Animals; Arachidonic Acid; Blood Glucose; Diabetes Mellitus, Experimental; Embryo, Mammalian; Embryo | 1998 |
A transgenic animal model of osmotic cataract. Part 1: over-expression of bovine Na+/myo-inositol cotransporter in lens fibers.
Topics: Animals; Carrier Proteins; Cataract; Cell Differentiation; Chromatography, Ion Exchange; Disease Mod | 1999 |
Folic acid supplementation of pregnant mice suppresses heat-induced neural tube defects in the offspring.
Topics: Analysis of Variance; Animals; Diet; Embryonic and Fetal Development; Female; Folic Acid; Hematinics | 1999 |
Culture of one-cell hamster embryos with water soluble vitamins: pantothenate stimulates blastocyst production.
Topics: Animals; Blastocyst; Choline; Cricetinae; Culture Media; Culture Techniques; Dose-Response Relations | 2000 |
Uptake and incorporation of myo-inositol by bovine preimplantation embryos from two-cell to early blastocyst stages.
Topics: Animals; Blastocyst; Cattle; Embryo, Mammalian; Embryonic Development; Female; Inositol; Inositol Ph | 2000 |
Lithium treatment in ovo: effects on embryonic heart rate, natural death of ciliary ganglion neurons, and brain expression of a highly conserved chicken homolog of human MTG8/ETO.
Topics: Amino Acid Sequence; Animals; Apoptosis; Base Sequence; Blotting, Northern; Blotting, Western; Brain | 2000 |
Inositol and folate resistant neural tube defects.
Topics: Adult; Female; Folic Acid; Humans; Inositol; Male; Neural Tube Defects; Pregnancy; Ultrasonography | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality.
Topics: Adult; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Humans; Inositol; Oocytes; Ovari | 2002 |
1H-NMR spectroscopy of cerebrospinal fluid of fetal sheep during hypoxia-induced acidemia and recovery.
Topics: 3-Hydroxybutyric Acid; Acidosis; Animals; Choline; Citric Acid; Creatinine; Energy Metabolism; Femal | 2002 |
myo-Inositol deficiency: studies on the mechanism of lactation-dependent fatty liver formation in the rat.
Topics: Animals; Fatty Liver; Female; Inositol; Lactation; Lipids; Liver; Microsomes, Liver; Palmitic Acids; | 1979 |
Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring.
Topics: Animals; Brain Chemistry; Computers; Estrus; Female; Ganglia, Autonomic; Gas Chromatography-Mass Spe | 1977 |
Cyclical changes in the carbohydrate composition of dog endometrium.
Topics: Animals; Carbohydrates; Dogs; Endometrium; Estrus; Female; Fructose; Glucose; Glucuronates; Inositol | 1979 |
Characterization of the lactation-dependent fatty liver in myo-inositol deficient rats.
Topics: Animals; Cholesterol; Cholesterol Esters; Fatty Liver; Female; Inositol; Lactation; Lipid Metabolism | 1977 |
myo-Inositol metabolism during lactation and development in the rat. The prevention of lactation-induced fatty liver by dietary myo-inositol.
Topics: Amniotic Fluid; Animals; Body Weight; Disaccharides; Fatty Liver; Female; Galactose; Inositol; Lacta | 1976 |
Biosynthesis of 6-beta-galactinol by beta-galactosidase from rat mammary gland and E. coli.
Topics: Animals; Chromatography, Gas; Escherichia coli; Female; Galactose; Galactosidases; Glycosides; Hydro | 1975 |
Characterization and tissue distribution of 6-O-beta-D-galactopyranosyl myo-inositol in the rat.
Topics: Animals; Chromatography, Gas; Colostrum; Disaccharides; Female; Galactose; Humans; Inositol; Lactati | 1975 |
The content of free and bound inositol in human and cow's milk.
Topics: Animals; Cattle; Colostrum; Evaluation Studies as Topic; Female; Flame Ionization; Humans; Inositol; | 1975 |
A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum.
Topics: Abortion, Spontaneous; Animals; Blastocyst; Blood Physiological Phenomena; Culture Media; Embryo Tra | 1992 |
Modulation of luteinizing hormone-stimulated inositol phosphate accumulation by phorbol esters in bovine luteal cells.
Topics: Animals; Calcium; Cattle; Cyclic AMP; Dinoprost; Female; Inositol; Inositol Phosphates; Kinetics; Lu | 1992 |
Levels of inositol metabolites within normal myeloid blast cells and changes during their differentiation towards monocytes.
Topics: Abortion, Spontaneous; Cell Differentiation; Cells, Cultured; Chromatography, High Pressure Liquid; | 1992 |
Stimulation of phosphatidylinositol hydrolysis by brain-derived neurotrophic factor and neurotrophin-3 in rat cerebral cortical neurons developing in culture.
Topics: Animals; Autoradiography; Brain-Derived Neurotrophic Factor; Carbazoles; Cells, Cultured; Cerebral C | 1992 |
Effects of maternal protein-calorie malnutrition on the phospholipid composition of surfactant isolated from fetal and neonatal rat lungs. Compensation by inositol and lipid supplementation.
Topics: Animals; Animals, Newborn; Fat Emulsions, Intravenous; Female; Fetus; Inositol; Lung; Male; Maternal | 1992 |
Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozocin-induced diabetic rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Diet; Embryonic and Fetal Development; Female | 1991 |
Evidence for direct non-genomic effects of triiodothyronine on bone rudiments in rats: stimulation of the inositol phosphate second messenger system.
Topics: Animals; Bone and Bones; Cells, Cultured; Chromatography, High Pressure Liquid; Diiodotyrosine; Dose | 1991 |
Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: prevention of dysmorphogenesis with aldose reductase inhibitors and myo-inositol.
Topics: Aldehyde Reductase; Animals; Blood; Congenital Abnormalities; Culture Media; Culture Techniques; Fem | 1991 |
Perinatal development of inositol synthesis and catabolism in rabbit kidney.
Topics: Aging; Amniotic Fluid; Animals; Animals, Newborn; Betamethasone; Female; Fetus; Inositol; Inositol O | 1991 |
Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy.
Topics: Animals; Aorta; Arginine Vasopressin; Female; Inositol; Inositol Phosphates; Phosphatidylinositols; | 1991 |
Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathways.
Topics: Arachidonic Acid; Arachidonic Acids; Enzyme Activation; Female; Humans; Hydrolysis; Inositol; Melitt | 1991 |
Inositol phosphate formation in uterine tissue from two species of reptiles is stimulated by arginine vasotocin and influenced by stage of reproduction.
Topics: Animals; Female; Inositol; Inositol Phosphates; Lizards; Pregnancy; Reproduction; Signal Transductio | 1991 |
Insulin mediators are the signal transduction system responsible for insulin's actions on human placental steroidogenesis.
Topics: 3-Hydroxysteroid Dehydrogenases; Antibodies; Aromatase Inhibitors; Female; Humans; Inositol; Insulin | 1991 |
Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition.
Topics: Adult; Breast Feeding; Colostrum; Female; Fetal Blood; Humans; Infant Food; Infant, Newborn; Infant, | 1990 |
Polyol pathway and fetal malformations: a search for the right mode of prevention.
Topics: Aldehyde Reductase; Animals; Congenital Abnormalities; Female; Fetal Diseases; Glucose; Inositol; Pr | 1990 |
Pregnancy suppresses G protein coupling to phosphoinositide hydrolysis in guinea pig myometrium.
Topics: Animals; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; | 1990 |
Glucose-induced dysmorphogenesis in the cultured rat conceptus: prevention by supplementation with myo-inositol.
Topics: Animals; Congenital Abnormalities; Culture Media; Culture Techniques; Disease Models, Animal; Embryo | 1990 |
Oxytocin-stimulated inositol phosphate turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins.
Topics: Animals; Endometrium; Estrus; Female; Inositol; Inositol 1,4,5-Trisphosphate; Interferon Type I; Oxy | 1990 |
Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia.
Topics: Animals; Biological Transport; Congenital Abnormalities; Culture Techniques; DNA; Embryo, Mammalian; | 1990 |
Retinopathy in the pregnant diabetic.
Topics: Adult; Blood Flow Velocity; Diabetic Angiopathies; Diabetic Retinopathy; Enzymes; Female; Fluorescei | 1985 |
Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia.
Topics: Adult; Cataract; Female; Galactitol; Galactokinase; Galactosemias; Genetic Carrier Screening; Humans | 1989 |
Inositol and choline levels in the diet and neutral lipid hepatic content of lactating rat.
Topics: Animals; Body Weight; Choline; Dietary Proteins; Female; Inositol; Lactation; Lipoproteins; Liver; O | 1989 |
Regulation and location of phosphatidylglycerol and phosphatidylinositol synthesis in type II cells isolated from fetal rat lung.
Topics: Animals; Binding Sites; Cells, Cultured; Endoplasmic Reticulum; Female; Inositol; Lung; Phosphatidyl | 1985 |
Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells.
Topics: Arachidonic Acid; Arachidonic Acids; Female; Humans; Hydrolysis; In Vitro Techniques; Inositol; Phos | 1985 |
Isolation of D-myo-inositol 1:2-cyclic phosphate 2-inositolphosphohydrolase from human placenta.
Topics: Annexin A3; Calcium; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Female; Humans; Inosi | 1986 |
Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Congenital Abnormalities; Culture Techniques; Female; Fe | 1986 |
Structure and function of phosphatidylglycerol-deficient lung surfactant.
Topics: Animals; Female; Fetus; Inositol; Lung; Male; Phosphatidylglycerols; Pregnancy; Pulmonary Surfactant | 1986 |
Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
Topics: beta-Glucosidase; Electrophoresis; Electrophoresis, Cellulose Acetate; Female; Fibroblasts; Gaucher | 1988 |
Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses.
Topics: Animals; Betamethasone; Body Weight; Female; Fetal Organ Maturity; Glucose; Inositol; Lung; Pregnanc | 1988 |
Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Body Weight; Creatine; Diabetes Mellitus, Ex | 1988 |
Lactation response to short-term abomasal infusion of choline, inositol, and soy lecithin.
Topics: Abomasum; Animals; Cattle; Choline; Female; Inositol; Lactation; Phosphatidic Acids; Phosphatidylcho | 1987 |
Studies on phosphatidylinositol metabolism and dexamethasone inhibition of proliferation of human palatal mesenchyme cells.
Topics: Cell Division; Cells, Cultured; Cortodoxone; Dexamethasone; Embryo, Mammalian; Female; Humans; Inosi | 1986 |
Inositol and hepatic lipidosis. II. Effect of inositol supplementation and time from parturition on serum insulin, thyroxine and triiodothyronine and their relationship to serum and liver lipids in dairy cows.
Topics: Animals; Biopsy, Needle; Cattle; Cattle Diseases; Female; Inositol; Insulin; Lipid Metabolism; Lipid | 1986 |
Inositol and hepatic lipidosis. I. Effect of inositol supplementation and time from parturition on liver and serum lipids in dairy cattle.
Topics: Animals; Biopsy, Needle; Cattle; Cattle Diseases; Cholesterol; Fatty Acids, Nonesterified; Female; I | 1986 |
Gestational age-dependent changes in plasma inositol levels and surfactant composition in the fetal rat.
Topics: Amniotic Fluid; Animals; Female; Fetal Blood; Gestational Age; Inositol; Lung; Phosphatidylcholines; | 1986 |
Oxytocin and vasopressin stimulate inositol phosphate production in human gestational myometrium and decidua cells.
Topics: Arginine Vasopressin; Calcium; Decidua; Female; Humans; Hydrolysis; In Vitro Techniques; Inositol; I | 1986 |
Role of myo-inositol in impairment of fetal lung phosphatidylglycerol biosynthesis in the diabetic pregnancy: physiological consequences of a phosphatidylglycerol-deficient surfactant in the newborn rat.
Topics: Animals; Animals, Newborn; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Female; Glycerol; | 1986 |
Intestinal absorption of calcium.
Topics: Administration, Oral; Age Factors; Aged; Bile; Calcium; Calcium, Dietary; Cholecalciferol; Depressio | 1973 |
[Artificial insemination in turkeys and an investigation into a suitable diluent of turkey semen (author's transl)].
Topics: Animals; Calcium Chloride; Cell Movement; Citrates; Cysteine; Female; Glucose; Glutamates; Hydrogen- | 1972 |
Studies on the developmental pattern of the enzymes converting glucose 6-phosphate to myo-inositol in the rat.
Topics: Animals; Carbohydrate Epimerases; Colostrum; Female; Glucosephosphates; Humans; Inositol; Lactation; | 1974 |
Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes.
Topics: Ammonia; Animals; Benzenesulfonates; Carbohydrate Epimerases; Chromatography, Gel; Female; Fructosep | 1974 |
Calcium metabolism in pregnancy and in the newborn.
Topics: Alkaline Phosphatase; Animals; Asian People; Black People; Blood Chemical Analysis; Calcium; Diet; F | 1974 |
Purification and properties of human alpha-galactosidases.
Topics: Ammonium Sulfate; Animals; Antibody Specificity; Chromatography, DEAE-Cellulose; Chromatography, Gel | 1972 |
Analysis of oxygen equilibrium of hemoglobin and control mechanism of organic phosphates.
Topics: Blood; Diphosphoglyceric Acids; Female; Fetal Hemoglobin; Glyceric Acids; Hemoglobins; Humans; Inosi | 1973 |
Identification of 6-0-beta-D-galactopyranosyl myo-inositol: a new form of myo-inositol in mammals.
Topics: Animals; Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Paper; Disaccharides; Fe | 1974 |
Skeletal muscle lipids. II. Changes in phospholipid composition in man from fetal to middle age.
Topics: Adolescent; Adult; Aging; Brain; Cardiolipins; Child; Child, Preschool; Chromatography, DEAE-Cellulo | 1974 |
Proceedings: Biochemical studies on Fallopian tube secretions.
Topics: Animals; Chromatography; Estradiol; Estrogens; Estrus; Fallopian Tubes; Female; Inositol; Pregnancy; | 1974 |
Skeletal muscle lipids. I. Changes in fatty acid composition of lecithin in man during growth.
Topics: Abortion, Legal; Adolescent; Adult; Aging; Amino Alcohols; Child, Preschool; Chromatography, Gas; Ch | 1971 |
Neutral carbohydrates in the milk of the bottlenose dolphin (Tursiops truncatus).
Topics: Animals; Carbohydrates; Chromatography, Gas; Chromatography, Paper; Dolphins; Female; Galactose; Glu | 1971 |
Isolation and identification of free myo-inositol and scyllo-inositol in cell nuclei.
Topics: Animals; Brain Chemistry; Cattle; Cell Nucleus; Chromatography, Gas; Female; Fetus; Guinea Pigs; Hum | 1969 |
Observations on the synthesis, chemical hydrolysis in vitro and toxicity of a new ester of nicotinic acid: the mesoinosito pentanicotinate.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Blood; Body Weight; Chemistry, Pharmaceutica | 1970 |
[Clinical experience report on veno-hexanicit].
Topics: Amines; Esters; Female; Genital Diseases, Female; Humans; Inositol; Nicotinic Acids; Postoperative C | 1970 |
The concentration of free meso-inositol in the plasma of perfused sheep foetuses.
Topics: Acetates; Acetoacetates; Animals; Biological Assay; Female; Fetus; Fructose; Glucose; Inositol; Mate | 1968 |
Preliminary study of carbohydrates in the urine of manganese-deficient guinea pigs at birth.
Topics: Animals; Animals, Newborn; Arabinose; Carbohydrates; Chromatography, Paper; Creatinine; Deficiency D | 1968 |
The placental transfer of hexoses and polyols in the guinea-pig, as shown by umbilical perfusion of the placenta.
Topics: Alcohols; Animals; Blood Glucose; Chromatography; Erythritol; Female; Galactose; Guinea Pigs; Inosit | 1966 |
Changes with age in the utilization of glucose carbon in liver and brain.
Topics: Aging; Amino Acids; Animals; Animals, Newborn; Aspartic Acid; Brain; Carbon; Carbon Isotopes; Centri | 1966 |